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The aim of this thesis was to investigate executive functions in obstructive sleep apnea
syndrome (OSAS). The specific focus was to identify the most affected domains of
executive functioning, to establish the severity of dysfunction and to determine the effect
of continuous positive airway pressure (CPAP) treatment on executive dysfunction. In
addition, verbal and visual cognitive functions were evaluated along with changes in
sleep depth.
The first step was to review earlier studies concerning executive functions in OSAS.
Next, in a series of original studies, 40 newly-diagnosed OSAS patients and 20 healthy
controls underwent a polysomnography and a neuropsychological assessment focusing on
executive functions. The 20 regular CPAP users were followed up after six months with a
polysomnography and a neuropsychological assessment, and 17 of the 20 controls were
followed up with a neuropsychological assessment. A subgroup of 15 patients and 15
controls were included in a separate study on verbal and visual cognitive functions and
local sleep depth using EEG.
The review of earlier studies showed that OSAS patients had decline in working
memory, set shifting, behavioural inhibition, phonological fluency and visuospatial
organizational skills, but the results were not consistent. With CPAP, OSAS patients’
performance time in the behavioural inhibition task improved and the number of errors in
the set shifting task decreased, but in other domains the deficits continued to persist.
In the original studies for this thesis, OSAS patients showed impaired executive
functioning compared to healthy controls in visuospatial organizational skills and set
shifting. However, normative analysis suggested that most OSAS patients had normal
performance and only a minority had mild to severe dysfunction. CPAP did not improve
executive dysfunction, and patients showed no learning effect in executive tests while
6healthy controls did. In addition, OSAS patients who showed mild visual cognitive
dysfunction also had a reduced amount of deep sleep in the right hemisphere.
Executive dysfunction in OSAS seems to be limited to visuospatial organizational
skills and set shifting. Only a minority of patients show impaired performance, but the
impairment may persist even after long-term treatment.
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1. INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is the most common cause of sleep apnea. It
is characterized by repetitive episodes of upper airway obstruction during sleep
(American Academy of Sleep Medicine, 2005). The condition results in blood gas
abnormalities and fragmented sleep. Up to 4% of men and 2% of women have clinically
important sleep apnea (Young et al., 1993). Common daytime symptoms are excessive
daytime sleepiness, reduced quality of life, mood changes and cognitive symptoms.
OSAS also has social consequences and it increases the risk of impaired working ability
and traffic accidents (American Academy of Sleep Medicine, 2005). OSAS is commonly
treated with continuous positive airway pressure (CPAP) (McMahon, Foresman, &
Chisholm, 2003).
The relationship between OSAS and cognitive symptoms is complex and the
research evidence is inconsistent (Aloia, Arnedt, Davis, Riggs, & Byrd, 2004; Beebe,
Groesz, Wells, Nichols, & McGee, 2003; Engleman, Kingshott, Martin, & Douglas,
2000). According to Beebe and Gozal (2002) executive functions (e.g. planning,
decision-making, flexible thinking) are among the most affected cognitive skills, because
fragmented sleep, hypoxemia and hypercapnia associated with OSAS primarily affect the
frontal areas of the brain. This thesis investigated executive functions in OSAS both
before and after CPAP treatment.
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1.1 Obstructive sleep apnea syndrome
Alternate terms for OSAS are obstructive sleep apnea, sleep apnea, sleep apnea
syndrome, obstructive apnea, mixed sleep apnea, sleep-disordered breathing, sleep
hypopnea syndrome and upper airway obstruction (American Academy of Sleep
Medicine, 2005). Upper airway resistance syndrome is also subsumed under this
diagnosis because the underlying pathophysiology is essentially the same as in OSAS.
Research into OSAS over the past 40 years has helped to give a clearer
understanding of the condition (Dempsey, Veasey, Morgan, & O’Donnell, 2010). The
syndrome was first described in the latter half of the 19th century (Lavie, 2003). These
first descriptions were case reports of obese persons suffering from extreme daytime
sleepiness and the syndrome was termed the “Pickwickian syndrome” after a character in
Charles Dickens’ The Pickwick Papers (Lavie, 2003). Although periodic breathing was
also recognized in other patient groups, including heart failure patients (Lavie, 2003), the
link between obesity, daytime sleepiness and control of breathing was not understood
until the 1950s and the discovery of periodic breathing as part of the Pickwickian
syndrome (Bickelmann, Burwell, Robin, & Whaley, 1956). At that time, however, no
connection was drawn with sleep disorder but it was thought that daytime sleepiness was
caused by “carbon dioxide poisoning” induced by respiratory failure. When the effects of
sleep on ventilation were discovered in the 1960s, Gastaut, Tassinari and Duron (1966)
developed a comprehensive view on OSAS by linking obesity, sleep-induced airway
obstruction, sleep fragmentation and daytime sleepiness.
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After these key observations, case reports were published of OSAS and
tracheostomies as a treatment method (Lugaresi, Coccagna, Mantovani, & Brignani,
1971). Research was active in the late 1970s and early 1980s, including extensive
physiological research on sleep and breathing (Dempsey et al., 2010) and the landmark
discovery of non-invasive CPAP treatment (Sullivan, Issa, Berthon-Jones, & Eves, 1981).
The association between OSAS, hypertension and cardiovascular diseases was discovered
in the 1990s (Fletcher, Lesske, Qian, Miller, & Unger, 1992). Soon after it was
discovered that OSAS was highly prevalent in the middle-aged nonclinical population
leading to a better understanding of the importance of this undiagnosed syndrome to
public health (Young et al., 1993). Since then there has been a huge increase in basic,
clinical and population research (Dempsey et al., 2010).
1.1.1 Diagnosis and treatment
OSAS refers to repetitive episodes of either complete (apnea) or partial (hypopnea)
obstruction of the upper airway during sleep (American Academy of Sleep Medicine,
2005; Dempsey et al., 2010). Obstructive events cause a cessation or reduction of airflow
but ongoing respiratory efforts, and an over-compensatory response by the autonomic
nervous system (American Academy of Sleep Medicine, 2005; Dempsey et al., 2010).
The condition results in significant arterial hypoxemia and hypercapnia and arousals from
sleep.
The diagnosis of OSAS takes into account both clinical and polysomnographic
features. Nocturnal symptoms of OSAS include loud snoring and breathing interruptions
often reported by the bed partner (American Academy of Sleep Medicine, 2005). Other
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common symptoms are gasping and choking during sleep, unrefreshing sleep, sweating
and nocturia. Daytime symptoms include morning headache, excessive daytime
sleepiness, fatigue and unintentional sleep episodes, as well as changes in libido, quality
of life, mood and cognition (Aloia et al., 2004; American Academy of Sleep Medicine,
2005; Beebe et al., 2003; Engleman et al., 2000; Harris, Glozier, Ratnavadivel, &
Grunstein, 2009; Reimer & Flemons, 2003). The severity of OSAS as measured by the
frequency of respiratory breathing events during sleep correlates poorly with the severity
of daytime symptoms (American Academy of Sleep Medicine, 2005).
The techniques of polysomnographic recording used in the diagnosis of OSAS are
highly standardized (Iber, Ancoli-Israel, Chesson, & Quan, 2007). The apnea-hypopnea
index (AHI) is used to describe the number of complete and partial obstructive events per
hour of sleep. OSAS severity is usually determined as follows: AHI 5-15 indicates mild,
6-30 moderate and over 30 severe OSAS. The oxygen saturation index (ODI4%)
describes the number of at least 4% drops in blood oxygen levels per hour of sleep. Slight
hypercapnia also occurs during obstructive events. The arousal index (ARI) indicates the
number of arousals per hour and is one indicator of sleep fragmentation (American
Academy of Sleep Medicine, 2005).
OSAS can occur in any age group, but its prevalence increases in middle-aged
and older adults. In women, the prevalence of OSAS increases after menopause. Obesity
is a major predisposing factor to OSAS. Patients with below normal or normal body
weight suffer from OSAS mainly because of localized structural upper airway
abnormalities, such as maxillomandibular malformation and adenotonsillar enlargement.
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Smoking and alcohol also increase the risk of OSAS (American Academy of Sleep
Medicine, 2005).
OSAS is associated with other health problems such as hypertension, metabolic
syndrome, diabetes and an increased risk of cardiovascular and cerebrovascular diseases
(American Academy of Sleep Medicine, 2005; Dempsey et al., 2010), as well as other
sleep disorders including parasomnias, insomnia and restless legs syndrome (American
Academy of Sleep Medicine, 2005; Rodrigues et al., 2007; Lavie, 2007).
Treatments for OSAS include weight loss, sleep hygiene, postural treatment,
mechanical advancement devices, surgical procedures and CPAP treatment (McMahon,
Foresman, & Chisholm, 2003). CPAP is a common and effective treatment especially for
moderate and severe OSAS. CPAP treatment involves the use of a nasal mask attached to
a pneumatic pump which supplies constant positive air pressure to the upper airway,
preventing collapses during sleep and stimulating normal breathing. CPAP improves
oxygen saturation and reduces sleep fragmentation.
1.1.2 Sleep quality and sleep stage fragmentation
Quality of sleep and sleep stage fragmentation can be studied using sleep
electroencephalography (EEG). Sleep is divided into REM (rapid eye movement) sleep
and NREM (non rapid eye movement) sleep. According to the sleep stages defined by
Rechtschaffen and Kales (1968), NREM sleep stage 1 (S1) is a transition phase between
wakefulness and sleep; sleep stage 2 (S2) indicates light sleep; and stages 3 (S3) and 4
(S4) consist of deep sleep and together constitute slow wave sleep (SWS). The thinking is
that the amount of SWS is especially important to good sleep quality and refreshing sleep
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(Kecklund & Åkerstedt, 1997; Åkerstedt, Hume, Minors, & Waterhouse, 1997). SWS
seems to vary in different brain areas; EEG changes induced by sleep deprivation suggest
that the left hemisphere needs more SWS than the right hemisphere (Achermann, Finelli,
& Borbely, 2001), and the frontal cortex seems to need more SWS than more posterior
parts of the cortex (Kubicki, Herrmann, & Höller, 1985). This may be explained by the
high level of activity of both the left hemisphere and frontal cortex during wakefulness. It
seems that the right hemisphere can better maintain its normal functioning when the brain
is going to sleep or is in sleep and that it can also better tolerate sleep loss (Casagrande &
Bertini, 2008a and 2008b).
The effects of OSAS on sleep fragmentation are stage specific because
obstructive events occur more frequently in NREM sleep stages 1 and 2 and in REM
sleep than in SWS (American Academy of Sleep Medicine, 2005). In OSAS, the amount
of sleep stage 2 increases, while the amount of SWS usually decreases and there is only a
minor reduction of REM sleep (Sanchez, Martinez, Miro, Bardwell, & Buela-Casal,
2009). In OSAS patients, fragmented sleep seems to cause frontally located sleep EEG
differences compared to healthy controls. In untreated OSAS patients the amount of slow
delta wave sequences in the left prefrontal cortex has been reported to be lower than in
controls (Himanen, Joutsen, & Virkkala, 2004; Huupponen et al., 2005). In addition, it
has been reported that CPAP increases SWS more in the left frontal than in the left
central cortex, suggesting that before treatment OSAS patients have a reduced amount of
SWS especially frontally, but CPAP moves EEG indices of sleep quality in a more
normal direction (Eskelinen, Uibu, & Himanen, 2007). The reduced amount of frontal
SWS seen in OSAS patients may impact patients' daytime performance because the
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frontal cortex is highly active during wakefulness and needs more recovering slow wave
activity during sleep (Rector et al., 2009). Earlier studies have investigated sleep depth
changes in OSAS patients in one hemisphere only (Himanen et al., 2004; Eskelinen et al.,
2007). An investigation of sleep depth changes in both hemispheres could clarify whether
there are hemispheric-specific changes and whether these changes are associated with
specific cognitive symptoms.
1.2 Cognitive symptoms and executive dysfunction associated
with sleep apnea
The relationship between cognitive symptoms and OSAS has received increasing
research attention since the 1980s. The very first studies on the relationship between
OSAS and cognition reported that some cognitive domains are affected while others are
not (Findley et al., 1986; Greenberg, Watson, & Deptula, 1987; Kales et al., 1985).
However, from the outset there have also been studies reporting no impairment in OSAS
patients’ cognitive skills (Knight et al., 1987).
1.2.1 General cognitive symptoms
Subjective reports of concentration and memory problems in OSAS are common. In a
study using Calgary Sleep Apnea Quality of Life Index (SAQLI) 70% of the 113 OSAS
patients reported a decreased ability to concentrate and 66% reported a decreased ability
to remember things (Flemons & Reimer, 1998). The prevalence of cognitive symptoms as
assessed by objective methods is not known because there are no prevalence studies with
large enough samples. Reviews (Aloia et al., 2004; Beebe et al., 2003; Decary, Rouleau,
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& Montplaisir, 2000; Engleman & Douglas, 2004) have found that when compared to
either control or norm-referenced data, OSAS patients show most consistently
impairment in attention, especially vigilance, executive functions, learning and memory,
visuoconstructive abilities and psychomotor functioning. The results concerning the
effect of OSAS on general cognitive performance level are inconsistent; some reviews
report a decline (Decary et al., 2000) while others do not (Aloia et al., 2004; Beebe et al.,
2003).
Cognitive deficits are related to the severity of OSAS as determined by the
frequency of respiratory breathing events, but the correlation is not clear or linear
(Engleman et al., 2000). It is reported that moderate and severe OSAS are associated with
cognitive deficits, but in mild OSAS cognitive problems may not be evident (Engleman
& Douglas, 2004). The mechanisms behind cognitive deficits are not clearly understood.
Possible background variables include OSAS-related biological factors, such as
hypoxemia, hypercapnia, increased respiratory effect, sleep fragmentation and excessive
daytime sleepiness (Beebe & Gozal, 2002; Decary et al., 2000, Verstraeten, 2007).
Cognitive problems may also be increased by other OSAS-related health problems such
as hypertension, metabolic syndrome, diabetes or increased risk of cerebrovascular and
cardiovascular diseases. Old age may increase cognitive problems because of increased
cerebrovascular risk, sleep changes (Antonelli-Incalzi et al., 2004) and impaired
compensatory skills (Alchanatis et al., 2008). On the other hand, high primary cognitive
level can provide protection against cognitive problems (Alchanatis et al., 2005).
CPAP treatment generally improves cognitive performance but some deficits may
persist (Aloia et al., 2004; Sanchez et al., 2009). The positive effects of CPAP treatment
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are sensitive to the duration of and adherence to the treatment regimen (McMahon et al.,
2003). Attention and vigilance generally improves (Aloia et al., 2004; McMahon et al.,
2003). The results from studies investigating the effects of CPAP on memory are
inconsistent (McMahon et al., 2003). At least some deficits in executive functions,
constructional abilities and psychomotor functioning continue to persist (Aloia et al.,
2004; Decary et al., 2000). The persistent cognitive deficits raise the possibility of
biochemical or structural brain damage (Aloia et al., 2004; Beebe & Gozal, 2002).
1.2.2 Executive dysfunction
Executive functions refer to a person’s ability to respond in an adaptive manner to
changing situations and to engage successfully in purposive and self-serving behaviour
(Lezak, Howieson, & Loring, 2004). Executive functions are the basis for many
cognitive, social and emotional skills. Executive dysfunction is associated with
abnormalities in the frontal cortex and in the dense connections between the frontal
cortex and other cortical or subcortical areas (Lezak et al., 2004).
Among the best known theories of executive functions are those of Norman and
Shallice (1986; Shallice, 1988) and Baddeley (1986, 2000). Norman and Shallice’s theory
of supervisory attentional system (SAS) includes two complementary processes:
contention scheduling and SAS. Contention scheduling is for automatically implemented
responses and includes schemata or behavioral programs for completing routine tasks and
skills. However, when a task is novel or complex, the schemata are not enough but an
additional attentional system, SAS, is required. SAS makes it possible to function in
novel situations that are not well-known by formatting a new action model that fits the
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new situation and that can be flexibly reformatted when the situation changes. SAS
compromises different processes: working memory, monitoring, rejection of schemata,
spontaneous schema generation, adoption of processing mode, goal setting, delayed
intention marker realization, and episodic memory retrieval.
In Baddeley’s (1986, 2000) model of working memory, the central executive is a
modality-free attentional control system that selects and controls strategies needed in a
particular task or situation. The relevant information is temporarily stored by two
modality-dependent short-term memory storages, visuospatial sketchpad and
phonological loop. In addition, the episodic buffer stores multidimensional information
and provides a temporary interface between short-term memory storages and long-term
memory. The central executive controls what information is retrieved from the long-term
memory to working memory for the purposes of the current task, and what information
should be stored from working memory into the long-term memory for later use.
Beebe and Gozal (2002) say that in OSAS patients, executive functions are
among the most affected cognitive domains because sleep disruption, hypoxemia and
hypercapnia reduce sleep-related restorative processes and disturb cellular and chemical
homeostasis, which in turn leads to altered neuronal and glial viability, particularly in the
frontal cortex. They suggest that executive dysfunction in OSAS patients can cause
impairment in behavioural inhibition, set shifting, self-regulation of affect and arousal,
working memory, analysis/synthesis performance and/or contextual memory. Impairment
of these skills causes everyday problems in mentally manipulating information, planning,
decision-making, organization, flexible thinking and maintaining attention, motivation
and emotional state. A recent meta-analysis by Beebe et al. (2003) investigated the effect
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of OSAS on different cognitive skills and executive functioning displayed a moderate to
large mean effect size indicating substantial executive dysfunction in OSAS. Effects sizes
were larger in comparison to control-referenced data than in comparison to norm-
referenced data.
On the other hand it has also been suggested that in some cases executive
dysfunction may be explained by lower-level attentional deficits. Verstraeten and co-
workers (2004a, 2004b, 2007) have pointed out that some earlier studies concerning
executive functions in OSAS (e.g. Bedard et al., 1991; Redline et al., 1997) have not
taken adequate account of the effects of decreased alertness and therefore their findings
of executive dysfunction remain tentative. They conclude that higher-level executive
dysfunction in OSAS may actually be explained by impaired lower-level processes,
namely attentional capacity deficits such as slowed information processing and decreased
short-term memory span, and that these cognitive changes may be caused by basal
slowing due to sleepiness, not by frontal dysfunction.
1.2.3 Assessment of executive dysfunction
Even mild executive dysfunction in OSAS may adversely impact patients’ everyday life,
working ability and social relationships (Beebe & Gozal, 2002), which underlines the
importance of early detection of these symptoms. Executive functions are not usually
impaired across the board, but some skills are impaired while others are not (Burgess,
2003). To clarify the nature of executive dysfunction in OSAS, it is necessary to evaluate
different domains. Beebe and Gozal (2002) and Decary et al. (2000) have given their
recommendations as to which test methods should be used in the assessment of OSAS
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patients’ executive functions. These recommendations are summarized in Table 1.
Because executive tests are ‘one-shot’ tests based on novelty and strategy formation, the
test-retest reliability of these tests is often poor (Burgess, 2003). It is important to account
for possible learning effect when assessing OSAS patients’ executive function before and
after treatment.
The only way to assess executive functions is via other cognitive skills. This
means that executive functions must always be assessed as part of a more comprehensive
neuropsychological assessment so that the possible effects of other cognitive deficits can
be analysed (Burgess, 2003). The view of Verstraeten and co-workers (2004a, 2004b,
2007) emphasize that cognitive processing speed and short-term memory span are key
factors that must be taken into account in the assessment of executive functioning. Other
aspects that must be included are general cognitive level and verbal and visual cognitive
processes (Crawford & Henry, 2005).
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TABLE 1. An overview of methods recommended for the assessment of executive
functions in OSAS by Beebe & Gozal (2002) and Decary et al. (2000).
Domain of executive function Test method
Mental set shifting and abstract behaviour Wisconsin Card Sorting Test1
Trails B of Trail Making Test2
Conceptual and visuomotor tracking Trails A of Trail Making Test2
Planning and foresight Mazes3
Focal attention, shifting processes and
behavioural inhibition
Stroop test4
Organizational skills / analysis-synthesis
on the spatial domain
Copy of Rey-Osterreith Complex Figure5
Analysis/synthesis Fluency tasks3
Working memory Back digit strings3
Visual sequences3
N-back test3
Self-regulation of affect and arousal Behavior Rating Inventory of Executive
Functioning6
1Heaton et al., (1993); 2Armitage, (1946); 3Lezak et al., (2004); 4Golden, (1978);
5Osterrieth, (1944); 6Gioia et al., (2000).
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1.2.4  Verbal and visual cognitive functions
Executive tests are based on either verbal or visual material, and therefore the
performance of these tests also requires verbal or visual cognitive functions. In OSAS,
verbal cognitive skills such as naming and conceptual formatting are usually intact (Aloia
et al., 2004; Beebe et al., 2003), while verbal fluency, which requires both verbal skills
and executive functioning, is more often affected (Bedard et al., 1991 and 1993; Ferini-
Strambi et al., 2003; Lee et al., 1999; Salorio et al., 2002). Visuoconstructive and
visuomotor changes are reported quite often while other aspects of visual functioning
seem to be intact (Bedard et al., 1991 and 1993; Ferini-Strambi et al., 2003; Rouleau et
al., 2002). According to the meta-analysis by Beebe et al. (2003), OSAS affects
especially drawing and fine-motor coordination, but it has less effect on visual perception
and motor speed. It seems then that visual cognitive functions that involve both a visual
and executive component, are more easily affected in OSAS.
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2. AIMS OF THE STUDY
It is well-known that executive functions are among the most defected cognitive domains
in OSAS, but executive dysfunction is usually examined as a single cognitive domain,
without considering which executive domains are most vulnerable to the effects of
OSAS. This thesis presents a detailed investigation of executive functions in OSAS. The
work was based on the theory of Beebe and Gozal (2002), without forgetting the
objections raised by Verstraeten (2007). In addition, because EEG changes during sleep
may be related to OSAS patients’ cognitive symptoms, hemisphere-related cognitive
functions and local sleep depth changes were also investigated.  The aims were:
1) to review earlier studies concerning executive functions in OSAS, focusing
specifically on the assessment methods used, the executive domains that are most
frequently defected, and the impacts of CPAP treatment on executive functions;
2) to investigate whether newly-diagnosed OSAS patients have executive dysfunction
when compared to healthy controls, identify the executive domains most affected, and to
establish the severity of possible dysfunction;
3) to clarify the impact of long-term CPAP treatment on OSAS patients’ executive
dysfunction and investigate any possible learning effect in executive tests;
4) to establish whether OSAS patients demonstrate decline in verbal or visual cognitive




3.1 Review of earlier studies
In Study I, earlier research on executive functions in OSAS was reviewed by searching
MEDLINE and PSYCHLIT for articles published between January 1990 and December
2005. The search terms used were ‘obstructive sleep apnea and cognitive’ and
‘obstructive sleep apnea or neuropsychological’. The first search yielded 196 articles.
After exclusion criteria were applied (non-English articles, articles with non-human and
non-adult subjects, case reports, reviews, experimental studies, letters, commentaries,
abstracts and chapters of edited volumes) and when the review was narrowed to articles
reporting results on at least one executive function, 24 articles remained. The lists of
references of these 24 articles were searched, yielding 16 additional articles. The total
number of articles reviewed was thus 40.
3.2 Original studies
3.2.1 Subjects
The subjects of the original studies were investigated at Tampere University Hospital
sleep unit. In Study II, the sample included 40 newly-diagnosed male OSAS patients who
met the diagnostic criteria, who had received no previous treatment and whose first
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treatment choice was CPAP. The control group consisted of 20 healthy male volunteers.
In Study III, the 20 patients who used CPAP for at least four hours a night and at least
five nights a week for a period of six months or longer were included in a follow-up.
After at least six months, 17 of the original controls joined the follow-up assessment. In
Study IV, a subgroup of 15 patients who had participated in both baseline and follow-up
assessments as well as 15 original controls were included. The demographic, clinical and
polysomnographic characteristics of all subjects are presented in Table 2.
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TABLE 2. Demographic, clinical and polysomnographic characteristics of patients and
controls.
Patients (n = 40) Controls (n = 20) Difference1
Age 47.2 ± 7.8 (28-65) 42.9 ± 10.3 (29-63) ns
Education (yrs) 12.5 ± 3.0 (5-17) 13.8 ± 3.0 (8-17) ns
ESS 11.5 ± 3.8 (4-18) 4.5 ± 2.8 (0-11) p < 0.001
BMI 30.3 ± 4.6 (24-41) 24.9 ± 2.7 (20-30) p < 0.001
AHI, n/h 41.0 ± 22.8 (10-103) 2.5 ± 2.1 (0-5) p < 0.001
ARI, n/h 33.8 ± 19.2 (8-100) 13.0 ± 4.4 (4-23) p < 0.001
ODI4%, n/h 26.0 ± 22.3 (0-88) 0.8 ± 1.4 (0-6) p < 0.001
TST 426.9 ± 49.8 (325-532) 419.4 ± 54.7 (328-527) ns
SEI% 90.3 ± 6.2 (74-100) 89.6 ± 7.0 (74-98) ns
S1% 6.1 ± 3.9 (1-23) 6.3 ± 3.6 (2-16) ns
S2% 68.2 ± 9.7 (48-85) 60.5 ± 7.7 (45-72) p = 0.005
SWS% 8.2 ± 7.0 (0-23) 13.8 ± 6.8 (2-25) p = 0.005
REM% 17.6 ± 5.0 (6-28) 19.4 ± 4.7 (13-28) ns
1Mann-Whitney U test; p-value
Abbreviations
ESS = Epworth Sleepiness Scale; BMI = body mass index; AHI = apnea/hypopnea index;
ARI = arousal index; ODI4% = oxygen desaturation index; TST = total sleep time; SEI =
sleep efficiency index of total sleep time; S1% = sleep stage 1 percentage of total sleep
time; S2% = sleep stage 2 percentage of total sleep time; SWS% = slow wave sleep




Both the patients and controls were first interviewed by telephone to make sure they met
the initial eligibility criteria: a) age between 20 and 65 years, b) right-handedness, c) no
(other) sleep disorders, d) no clinically significant medical disorder (e.g. neurological
illness, psychiatric disorder, hypo-/hyperthyroidism or other lung diseases than currently
asymptomatic asthma), f) no medication affecting central nervous system, g) no
substance or alcohol abuse, and h) no self-reported primary sensory disorders. The
patients’ OSAS diagnosis and the controls’ healthiness were then confirmed in a clinical
interview and by means of a diagnostic full-night polysomnography in a sleep laboratory.
The diagnosis of OSAS was based on clinical picture and subjective complaints of OSAS
(American Academy of Sleep Medicine, 2005) and on an AHI > 10 per hour of sleep.
The controls had to be asymptomatic and to have an AHI of ? 5 per hour of sleep.
At baseline, patients and controls who according to the first night
polysomnography met the eligibility criteria underwent a second full-night
polysomnography; the latter recordings were used in the analyses. A neuropsychological
assessment focusing on executive functions was conducted the following morning.
After at least six months of CPAP treatment, patients returned for a full-night
polysomnography (the treatment night) and a neuropsychological control assessment the
following morning. Prior to the treatment night, objective compliance measures were
downloaded from CPAP units. The controls underwent a neuropsychological control
assessment after an interval of at least six months from the baseline assessment.
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3.2.3 Measures
Neuropsychological test methods were selected to assess general cognitive level, verbal
and visual cognitive functions, and different domains of executive functioning (Table 3).
Subjective sleepiness was assessed with the Epworth Sleepiness Scale (ESS;
Johns, 1991). Conventional polysomnographic variables were used as background
variables. In addition, in Study IV, deep sleep percentages (DS%) were calculated from
six EEG derivations, based on the work by Saastamoinen, Huupponen, Värri, Hasan and
Himanen (2007). The value of DS% indicated the proportion of NREM sleep time
containing deeper sleep than the threshold of 4.0 Hz.
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TABLE 3. Assessment of cognitive functions.
Domain Test method used
General cognitive level Wechsler Adult Intelligence Scale-Revised1 – short
version with seven subtests2
Verbal cognitive functions Information1, Digit Span1, Arithmetics1,
Similarities1, Semantic fluency3,  Phonological
fluency3
Visual cognitive functions Picture Completion1, Block Design1, Digit Symbol1,
Copy of the Rey-Osterrieth Complex Figure Test4
Verbal short-term memory span Digit Span forwards1
Verbal working memory Digit Span backwards1
Visual short-term memory span Spatial Span5: span length
Visual working memory Spatial Working Memory5: strategy
Verbal fluency Semantic: Animals3
Phonological: letters PAS (Finnish version of FAS3)
Visuospatial organizational
skills





Trails A of Trail Making Test6: time
Mental set-shifting Trails B of Trail Making Test6: time
Intra-Extra Dimensional Set Shift5: stages completed
and errors
Planning and problem-solving Stockings of Cambridge5: problems solved in
minimum moves
1Wechsler, (1981); 2Ward & Ryan, (1996); 3Lezak et al., (2004); 4Osterrieth, (1944);




4.1 Review of earlier studies
The studies reviewed (Study I) consisted mainly of working-age men with mild to severe
or moderate to severe OSAS. The most commonly used test methods were the
Phonological fluency tasks, Trail Making Test (TMT), Digit Span, Wisconsin Card
Sorting Test (WCST; Heaton, 1993), Stroop test (Golden, 1978), Tower tests (Lezak et
al., 2004), Rey-Osterrieth Complex Figure Test (ROCFT) and Corsi’s block-tapping test
(Lezak et al., 2004). There was much variation in terms of what the tests were thought to
measure, and some studies failed to determine what executive domain they wanted to
assess with the test. Half of the 40 studies reviewed used only one or two methods to
assess executive dysfunction, the other half assessed executive dysfunction using three to
nine tests.
Among the most commonly used tests, OSAS patients showed defected
performance most frequently in the Digit Span, Corsi-block tapping test, Trails B of the
TMT, Stroop test, Phonological fluency tasks and ROCFT, and they achieved fewer
categories and showed more perseverative errors in the WCST. With CPAP treatment,
OSAS patients’ performance time improved in the Stroop test and they had fewer
perseverative errors in the WCST, but in other domains the deficits continued to persist.
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4.2 Executive dysfunction before CPAP treatment
In Study II, working-aged male patients had mild to severe OSAS with arousals,
hypoxemic events and sleep stage changes, and they were sleepier and more obese than
healthy controls. The study groups did not differ in intelligence quotient (IQ). Patients
showed poorer set shifting performance than healthy controls as assessed with the Trails
B and Intra-Extra Dimensional Set Shift (IED), and lower visuospatial organizational
skills as assessed with the ROCFT and Block Design (Table 4). When performance in
these executive tests was compared with normative data, most OSAS patients showed
normal performance, but some demonstrated either mild (2-12.5%) or from moderate to
severe (5-15%) decline. The nine patients who showed moderate to severe deficits were
compared to the 31 patients with normal or only mildly impaired performance with
regard to age, years of education, IQ, ESS, body mass index (BMI) and
polysomnographic variables. No statistically significant differences were found.
4.3 Executive dysfunction after CPAP treatment
CPAP had the effect of normalizing OSAS patients’ respiratory deficits, arousals and
hypoxemic events, improving sleep quality, and decreasing subjective sleepiness (Study
III). Mean CPAP adherence was 6.2 hours per night (range 4.3-8.6), and the mean
duration of CPAP treatment was 7.4 months (range 6-12). Patients’ executive
performance showed no improvement, and they continued to perform more poorly than
controls. In addition, OSAS patients showed no learning effect in executive tests, while
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healthy controls improved their performance in the Block Design, Digit Symbol, Trails A
and Stockings of Cambridge (SOC).
TABLE 4. Mean  ± SD and (range) of executive tests in patients and controls.
Patients (n = 40) Controls (n = 20) Difference1
IQ 111.2 ± 9.7 (94-132) 117.6 ± 9.8 (104-137) ns
Digit Span forwards 6.9 ± 1.6 (4-10) 7.1 ± 1.9 (4-11) ns
Digit Span backwards 6.6 ± 1.3 (4-10) 6.7 ± 1.6 (4-10) ns
Spatial Span 6.6 ± 1.4 (3-9) 7.1 ± 1.4 (5-9) ns
Spatial Working Memory 30.6 ± 6.6 (19-43) 29.5 ± 6.9 (19-41) ns
Phonological fluency 24.8 ± 5.0 (13-34) 25.6 ± 4.4 (16-31) ns
Semantic fluency 39.7 ± 11.2 (18-74) 42.2 ± 11.2 (27-59) ns
ROCFT 33.6 ± 2.7 (26-36) 35.1 ± 1.0 (33-36) p = 0.041
Block Design 33.2 ± 8.3 (14-49) 39.1 ± 8.5 (23-51) p = 0.021
Digit Symbol 45.4 ± 11.6 (25-86) 54.0 ± 15.5 (33-88) ns
Trails A 31.5 ± 13.6 (17-73) 32.0 ± 10.6 (14-61) ns
Trails B 73.0 ± 47.4 (42-238) 61.5 ±  32.5 (31-159) p = 0.019
IED stages 8.6 ± 0.7 (7-9) 9.0 ± 0.0 (9-9) p = 0.021
IED errors 18.1 ± 11.5 (7-45) 13.0 ± 6.4 (7-28) ns
Stockings of Cambridge 9.7 ± 1.9 (3-12) 9.9 ± 2.1 (5-12) ns
1Mann-Whitney U test; p-value
Abbreviations
IQ = intelligence quotient; ROCFT = Copy of Rey-Osterrieth Complex Figure Test; IED
= Intra-Extra Dimensional Set Shift.
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4.4 Verbal and visual cognitive functions and local sleep depth
When verbal and visual cognitive functions were investigated (Study IV), OSAS patients
showed lower performance than controls in the Picture Completion, Digit Symbol and
ROCFT. The difference between the study groups remained after CPAP treatment in the
Picture Completion and ROCFT. Before CPAP, OSAS patients had a reduced amount of
deep sleep in both hemispheres frontally, centrally and occipitally compared to controls
(Table 5). After six months of CPAP treatment, patients’ amount of deep sleep increased
to the same level as in controls’ frontopolarly and centrally in the left hemisphere, while
patients continued to show a reduced amount of deep sleep in all three locations of the
right hemisphere and occipitally in the left hemisphere (Table 5). Patients also had a
lower amount of deep sleep in the right than in the left hemisphere both frontopolary and
centrally, while controls showed this inter-hemispheric difference only frontopolarly.
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A vs B1 A vs C1 B vs C2
DS(Fp1)% 24.8 ± 12.7 (6.2 - 48.8) 13.1 ± 10.6 (0.0 - 30.2) 18.3 ± 11.6 (0.0 - 33.3) p = 0.017 ns p = 0.036
DS(Fp2)% 21.1 ± 12.3 (0.0 - 39.3) 6.5 ± 7.7 (0.0 - 21.5) 10.3 ± 9.3 (0.0 - 24.7) p = 0.002 p = 0.018 ns
DS(C3)% 13.2 ± 11.0 (0.0 - 29.6) 4.8 ± 4.6 (0.0 - 11.8) 9.2 ± 8.3 (0.0 - 24.4) p = 0.024 ns p = 0.019
DS(C4)% 12.8 ± 10.2 (0.0 - 29.7) 2.8 ± 3.3 (0.0 - 11.9) 5.1 ± 5.4 (0.0 - 15.49 p = 0.016 p = 0.013 p = 0.022
DS(O1)% 10.0 ± 11.8 (0.0 - 37.4) 1.1 ± 2.6 (0.0 - 8.3) 2.2 ± 3.5 (0.0 - 9.89 p = 0.004 p = 0.027 ns
DS(O2)% 11.8 ± 12.6 (0.0 - 42.9) 1.5 ± 2.6 (0.0 - 9.1) 1.9 ± 3.1 (0.0 - 11.0) p = 0.016 p = 0.022 ns
1Mann-Whitney U test; 2Wilcoxon test; p-values
Abbreviations
DS(Fp1)%, DS(Fp2)%, DS(C3)%, DS(C4)%, DS(O1)%, DS(O2)% = computational deep sleep percentages extracted from EEG
channels Fp1-A2, Fp2-A1, C3-A2, C4-A1, O1-A2, O2-A1.
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5. DISCUSSION
The purpose of this thesis was to investigate executive functions in OSAS before and
after CPAP treatment. A further concern was with verbal and visual cognitive functions
and local sleep depth changes.
5.1 Assessment of executive functions
In the studies reviewed (Study I), executive functions were predominantly assessed using
the methods recommended by Decary et al. (2000) and Beebe and Gozal (2002). The use
of standardized tests makes for easier comparisons. However, the general lack of
theoretical agreement how executive functions are defined and operationalized, can be
seen also in the studies reviewed. Some studies failed to specify which executive domain
they were measuring, but set about assessing executive function as a single global
function. This may have led to the false conclusion that executive functions are either
totally impaired or totally intact. There were also marked differences in terms of what the
test was thought to measure. The use of a wide battery of executive tests helps to
overcome the problem that there is no common agreement about which executive aspect
even the most commonly used tests actually measure, but the disadvantage is that it
increases the likelihood of false-positive errors (Burgess, 2003).
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Half of the studies reviewed assessed executive functions with only one or two
test methods. This does not provide a sufficiently sound basis for drawing conclusions
and it is possible that this narrow assessment fails to recognize some executive
dysfunction. It should be also noted that neuropsychological tests may not be sensitive
enough to detect mild cognitive change and the positive treatment effects of CPAP,
especially in OSAS patients with a high general cognitive level (Lojander et al., 1999).
Recent studies (Lim et al., 2007; Lis et al., 2008) have shown that more complex
neuropsychological tasks (e.g. PASAT, n-back working memory tasks and Digit
Vigilance; see Lezak et al., 2004 for test descriptions), which require cognitive
processing speed, vigilance and working memory, seem to be more sensitive to detect
even mild changes. Assessment methods developed by experimental cognitive studies
may offer in the further more sensitive and specific tests to be used also in clinical
practice.
Learning effect in executive tests may be significant when retesting OSAS
patients after CPAP treatment. Especially in measurements of the short-term effects of
CPAP, OSAS patients seem to improve their performance over time, and without placebo
control this improvement may be misattributed to CPAP (Lim et al., 2007). In the
placebo-controlled studies reviewed, treatment time ranged from 1 to 8 weeks, which is
not necessarily enough to see an improvement in complex cognitive domain such as
executive functioning. Only a few studies explored the long-term effects of CPAP on
executive functions (Bedard et al., 1993; Ferini-Strambi et al., 2003; Feuerstein et al.,
1997; Naegele et al. 1998). These studies used parallel or alternative test versions at the
follow-up assessment to decrease the learning effect. However, this is not necessarily
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enough; when a patient figures out the basic idea of the test, it may be much easier to do
the second time round, even if the material is different from the original test.
5.2 Quality and quantity of executive dysfunction
In the original study (Study II) where OSAS patients’ executive functions were compared
with the control-referenced data, executive functions were only partly impaired and the
most defected domains were visuospatial organizational skills and set shifting. The
finding regarding lower visuospatial organizational skills is in line with earlier results
(Bedard et al., 1991; Ferini-Strambi et al., 2003; Rouleau et al., 2002). In contrast, the
finding of reduced set shifting performance as measured by the Trails B has previously
been reported only in a study by Bedard et al. (1991 and 1993); most earlier studies have
shown no change in this test (Ferini-Strambi et al., 2003; Feuerstein et al., 1997; Lee et
al., 1999; Naegele et al., 1995; Rouleau et al., 2002). However, the patients’ lower set
shifting observed in the present study is also supported by their reduced performance on
the IED. The IED is used to assess similar executive function to the WCST, and many
earlier studies have reported reduced performance in this test (Feuerstein et al., 1997; Lee
et al., 1999; Naegele et al., 1995; Redline et al., 1997; Roulaeu et al., 2002).
The present study did not confirm that OSAS patients have impaired working
memory or verbal fluency. Earlier studies have reported inconsistent findings for these
executive domains: some studies show impaired working memory (Felver-Gant et al.,
2007; Feuerstein et al., 1997; Lis et al., 2008; Naegele et al., 1995) and verbal fluency
(Bedard et al., 1991 and 1993; Ferini-Strambi et al., 2003; Lee et al., 1999; Salorio et al.,
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2002), while others conclude that working memory (Ferini-Strambi et al., 2003; Lee et
al., 1999; Yaouhi et al., 2009) and verbal fluency (Feuerstein et al., 1997; Naegele et al.,
1995; Rouleau et al., 2002; Yaouhi et al., 2009) are intact in OSAS.
When compared to norm-referenced data, most OSAS patients performed at
normal level and only some patients showed executive dysfunction. Although patients
with executive dysfunction seem to be a minority, it is important to detect these patients
because even mild executive dysfunction may have a negative impact on patients’
working ability, and moderate to severe deficits may cause significant everyday
problems. These patients cannot be identified on the basis of their background data: the
patients with moderate to severe executive dysfunction did not differ from those with
normal or only mildly impaired performance in terms of age, education, IQ, daytime
sleepiness, obesity, or conventional polysomnographic variables. Although the severity of
OSAS in the present study group varied from mild to severe, most patients had moderate
to severe OSAS. It is possible that this made them more vulnerable to cognitive changes.
Although patients did not have any other significant medical disorder, it is possible that
the existence of OSAS-related co-morbidities increased the risk of cognitive problems.
5.3 Effect of CPAP on executive dysfunction
After six months of CPAP treatment, OSAS patients’ performance in executive tests
showed no change and remained lower than in healthy controls (Study III). This confirms
the results of earlier studies that executive functions are not totally reversible even with
long-term CPAP treatment (Bedard et al., 1993; Ferini-Strambi et al., 2003; Feuerstein et
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al., 1997; Naegele et al. 1998). The results of the present study showing persisting decline
in set shifting are in line with the finding of Bedard et al. (1993), who reported that
impaired performance in the Trails B remained after six months of CPAP treatment.
Feuerstein et al. (1997) and Naegele et al. (1998), by contrast, reported that OSAS
patients’ set shifting performance as assessed with the WCST improved after 4-6 months
of CPAP treatment. Findings of persisting decline in visuospatial organizational skills are
consistent with the results of Ferini-Strambi et al. (2003), but in contrast to those of
Bedard et al. (1993). In placebo-controlled studies, Engleman et al. (1994; 1997) reported
that CPAP produced a greater improvement in set shifting as assessed with the Trails B
than did placebo treatment. However, most placebo-controlled studies have found no
improvement in either set shifting performance or in visuospatial organizational skills
over placebo (Bardwell et al., 2001; Barnes et al., 2002; Engleman et al. 1998; Lim et al.,
2007).
After CPAP treatment, OSAS patients showed no learning effect in executive
tests, while healthy controls did. This may have to do with the fact that executive
dysfunction and long-term memory deficits often overlap: frontal dysfunction may cause
poorer learning and memory skills because of deficits in memory organization (Salorio et
al., 2002). The recording of new experiences and consolidation of declarative memories
are dependent on the cooperation of prefrontal and hippocampal functions, and this
process can easily be disrupted by inadequate sleep, especially the lack of SWS (Walker,
2009) that is seen in OSAS patients. It is also possible that the finding of OSAS patients'
reduced amount of deep sleep in the right hemisphere have an association with their
impaired learning effect. In the study by Huber, Ghilardi, Massimini, and Tononi (2004),
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learning in a visuomotor task was followed by an increase in slow wave activity over the
right parietal cortex. On the other way round: decreased slow wave activity in the right
parietal brain area might decrease learning, at least in visuomotor tasks.
5.4 Visual cognitive dysfunction and local sleep depth changes
When verbal and visual cognitive functions and local sleep depth were investigated
(Study IV), OSAS patients showed mild visual dysfunction and a reduced amount of deep
sleep in the right hemisphere compared to controls even after long-term CPAP treatment.
The finding of mild visual cognitive dysfunction is in line with earlier results (Bedard et
al., 1991 and 1993; Ferini-Strambi et al., 2003; Rouleau et al., 2002). As in previous
reports, also in this study verbal cognitive skills remained intact (Aloia et al., 2004;
Beebe et al., 2003). On the other hand, in contrast to many other studies (Bedard et al.,
1991 and 1993; Ferini-Strambi et al., 2003; Lee et al., 1999; Salorio et al., 2002), this
study found no change either in verbal fluency tasks.
At baseline, OSAS patients showed a reduced amount of deep sleep compared to
controls in both hemispheres frontally, centrally, and occipitally. The reduced amount of
deep sleep might be connected to cognitive changes because deep sleep is thought to
express the refreshing effect of sleep (Kecklund & Åkerstedt, 1997; Åkerstedt et al.,
1997). However, even though the amount of deep sleep was reduced bilaterally, only
visual cognitive dysfunction was detected, not verbal. It can be speculated whether
compensatory mechanisms may explain intact verbal cognitive skills. In a recent study,
Aloia et al. (2009) reported that OSAS patients performed at the same level in a 2-back
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verbal memory task in the condition where patients were using CPAP and where CPAP
was withdrawn. However, in the condition where CPAP was withdrawn, functional
magnetic resonance imaging showed overactivation of the right inferior parietal lobule
and deactivation of the right posterior insula, suggesting compensatory function.
After CPAP, OSAS patients continued to show mild visual dysfunction and
reduced amount of deep sleep in the right hemisphere. This might indicate that this
dysfunction was in fact a result of visual cognitive change, although other cognitive
functions, especially executive functions, may also have an effect on patients'
performance. OSAS patients had a reduced amount of deep sleep compared to controls
bilaterally in the occipital brain areas before and after CPAP treatment, and the amount of
deep sleep in the occipital area did not increase significantly during treatment. It can be
speculated whether occipital deep sleep changes are related to the visual dysfunction
observed in OSAS patients.
Another noteworthy finding was the discovery that even healthy controls
presented an inter-hemispheric difference in the deep sleep percentage. This might be
connected to the findings of Casagrande and Bertini (2008a and 2008b), who proposed
that the right hemisphere could better maintain normal functioning during sleep and
monitor potential warning stimuli. If this theory is correct, it might be natural that healthy
controls have less deep sleep in the right than in the left frontopolar area during normal
sleep. However, OSAS patients showed a reduced deep sleep percentage in a larger area
of the right hemisphere than controls. This might indicate that in OSAS patients the right
hemisphere monitors possible internal warning stimuli such as signals about respiratory
deficits and the central cortex is also needed to make this possible. This fits in with the
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theory of Sturm et al. (1999) according to which the attention and vigilance system is
based on the right fronto-parietal-thalamic-brainstem network.
After CPAP treatment, OSAS patients continued to show inter-hemispheric deep
sleep difference in both the prefrontal and central cortex and a reduced amount of deep
sleep in the right hemisphere compared to controls. This raises the question as to whether
the right hemisphere continues to monitor respiratory deficits, even though CPAP
treatment is expected to prevent obstructive events, and whether the right hemisphere is
more vulnerable to the harmful effects of OSAS because of its dominance in this
vigilance system. In a recent study, Yaouhi et al. (2009) concluded that OSAS patients
who did not have notable cognitive deficits showed right-lateralized cerebral changes in
terms of both grey matter density and metabolic levels. They suspected that many
patients, especially with a high general cognitive level, compensate the functional effects
of brain changes at disease onset, but that there is a risk of changes causing more notable
cognitive consequences if OSAS is not treated.
5.5 Limitations
Most samples in the studies reviewed as well as in the original studies consisted of
working-age men. It is not known whether gender has an effect on OSAS patients’
cognitive symptoms, but it should be noted that these results can only be generalized to
male patients. The number of patients in our study was quite low, but nevertheless
comparable to the numbers in earlier studies focusing on OSAS patients’ executive
functions (Bedard et al. 1991 and 1993; Ferini-Strambi et al., 2003; Feuerstein et al.,
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1997; Lee et al., 1999; Naegele et al., 1995 and 1998; Roulaeu et al., 2002; Salorio et al.,
2002).
The search of reference lists in the studies reviewed (Study I) yielded a significant
number of additional articles. This suggests that the terms used in the literature search
were not inclusive enough. In particular, the use of alternative terms for obstructive sleep
apnea would have improved the coverage of the search. The use of meta-analysis would
also have made the review more exact.
There were some limitations in the original studies. Study II did not investigate
the effect of executive dysfunction on patients’ daily performance because of the lack of
adequate methods. In Study III, the patients who used CPAP adequately tended to be
older than those who did not. In addition, patients and controls differed in their sleep
conditions prior to the neuropsychological control assessment. This may have had some
effect on patients’ cognitive performance the following morning because of generally
poorer sleep quality in laboratory conditions. This may be particularly true in tasks that
require cognitive processing speed (e.g. Trails A). However, the impaired learning effect
seen in executive tests is mainly attributable to the long-term effects of OSAS. Study IV
used a subgroup of patients from the earlier studies. Verbal and visual cognitive functions
were assessed using partly the same test methods as were used to assess executive
functions in Studies II and III. However, because executive functions can only be
assessed via other cognitive skills, it is impossible to avoid the overlapping use of tests.
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5.6 Theoretical considerations and future directions
As described earlier, Beebe and Gozal (2002) suggest that executive functions may be
easily disturbed in OSAS because the frontal brain area is vulnerable to the cellular and
chemical effects of sleep fragmentation, hypoxemic and hypercapnic events. Verstraeten
(2007), on the other hand, argues that rather than frontally based executive dysfunction,
OSAS patients may in fact be showing decreased alertness and slowed information
processing speed due to sleepiness and basal slowing. Bearing in mind that fronto-
subcortical circuits of the brain are very dense, it is possible that both views of Beebe and
Gozal (2002) and Verstraeten (2007) are correct and that OSAS impacts both higher-level
executive functions and lower-level attentional skills. At least recent studies show that
OSAS patients’ working memory performance may be affected by both executive and
attentional deficits (Lis et al., 2008; Naegele et al., 2006). Considering the co-morbidities
of OSAS, it is also possible that vascular risk factors disturb mostly the dense fronto-
subcortical circuits, although Aloia et al. (2004) suspect that damage to the small vessels
of the brain results in cognitive problems that are not restricted to any particular domains.
Future research into the relationship between OSAS and cognitive dysfunction
should focus on prevalence issues, using objective neuropsychological assessment
methods to establish how large a proportion of OSAS patients have cognitive symptoms.
In addition, more research is needed to explore the background variables of cognitive
symptoms, especially the effect of co-morbidities of OSAS on patients’ cognition. The




The clinical investigation of OSAS patients does not routinely include a
neuropsychological assessment. However, such an assessment should be considered
whenever a patient reports cognitive problems in everyday life and a reduced capacity for
work or driving. The neuropsychological assessment of OSAS patients should be as
comprehensive as possible and include not only neuropsychological tests but also a
structured interview and self-assessment inventories. In addition to general cognitive
level and different aspects of memory, the assessment should compromise executive
functions, attention, information processing speed, visuoconstructive and visuomotor
functions. It is also important that clinicians are aware of the limitations of the test
methods. The use of tests that require both executive functioning, attention and
processing speed seem to be the most sensitive to detect OSAS-related cognitive
symptoms and the effects of CPAP treatment. Input is needed to develop assessment
methods that focus on the everyday consequences of cognitive symptoms.
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6. SUMMARY AND CONCLUSIONS
The main findings of the thesis are as follows:
1) The review of earlier research indicated that OSAS patients do not show impairment in
all executive functioning, but some domains are impaired while others are not. However,
executive dysfunction seems to persist mostly after CPAP treatment.
2) The original studies of this thesis showed that executive dysfunction is restricted
especially on impaired visuospatial organizational skills and set shifting, but based on the
normative analysis, most OSAS patients have normal performance and only a minority
show dysfunction.
3) Even long-term CPAP treatment does not efficiently improve impaired visuospatial
organizational skills and set shifting. In addition, OSAS patients show an impaired
learning effect in executive tests. This may be explained by the fact that executive
dysfunction and impaired learning skills often overlap.
4) Local sleep depth changes may help to better understand cognitive dysfunction in
OSAS. At the same time as OSAS patients show mild visual dysfunction, they have a
reduced amount of deep sleep in the right hemisphere. The right hemisphere may be more
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A review of executive functions in
obstructive sleep apnea syndrome
Introduction
According to the American Academy of Sleep
Medicine (1), obstructive sleep apnea syndrome
(OSAS) is characterized by repetitive episodes of
complete (apnea) or partial (hypopnea) obstruc-
tion of the upper airway during sleep. These
conditions usually result in oxygen desaturation
and arousals from sleep. Estimated prevalence of
clinically important sleep apnea is up to 4% in men
and 2% in women. The diagnosis of obstructive
sleep apnea is based on the following: (i) the
patient complains some of the following symp-
toms: unintentional sleep episodes during wakeful-
ness, daytime sleepiness, unrefreshing sleep,
fatigue, insomnia, gasping and choking, or the
bed partner reports breathing interruptions, and/or
loud snoring, and (ii) the polysomnographic
recording shows ﬁve or more respiratory breathing
events (apneas, hypopneas or respiratory effort
related arousals) per hour of sleep and evidence of
respiratory effort during all or a portion of each
respiratory event. The diagnostic criteria are also
fulﬁlled when (i) polysomnographic recording
shows 15 or more respiratory events per hour of
sleep and evidence of respiratory effort during all
or a portion of each respiratory event, and (ii) the
disorder is not better explained by another current
sleep disorder, medical or neurological disorder,
medications, or substance use disorder. The sever-
ity of OSAS varies among the patients. The
frequency of apneas and hypopneas during sleep
correlates poorly with the severity of daytime
symptoms. Excessive sleepiness is a major com-
plaint and is most evident in inactive situations
(e.g. watching television, reading, traveling as a
passenger). In severe sleep apnea extreme sleepi-
ness can occur during activities that require more
active attention (e.g. while eating, during conver-
sation, walking, or driving) (1).
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Objectives – To provide an update on recent research concerning
obstructive sleep apnea syndrome (OSAS) and executive
functions. Methods – A systematic review was carried out on reports
drawn from MEDLINE and PSYCHLIT (January 1990–December
2005) and identiﬁed from lists of references in these reports. The
selection criteria were met by 40 articles. Results – The sample sizes in
the reviewed studies varied widely and consisted mostly of selected
groups. Most patient samples were heterogeneous in terms of the
severity of OSAS. Executive functions were generally assessed with
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and planning. Deﬁcits in working memory and phonological ﬂuency
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Common symptoms of OSAS include mood
disorders, reduced quality of life and cognitive
problems (2). Cognitive impairment in sleep apnea
has been studied since the 1980s and several
authors have offered reviews of these studies
(2–9). According to these reviews the most
common cognitive deﬁcits are seen in attention or
concentration, vigilance, memory and learning
abilities, motor performance, constructional abilit-
ies and executive functions. Both excessive daytime
sleepiness and nocturnal hypoxemia contribute to
cognitive deﬁcits (3–5). Excessive daytime sleepi-
ness has been mostly related to impairment in
attention, vigilance and memory function, while
hypoxemia correlates more with deﬁcits in execu-
tive functions (2, 4). Cognitive impairment usually
worsens with disease severity, but this tendency is
not linear (8, 9).
Beebe and Gozal (10) recently reviewed the
importance of executive dysfunction and the
involvement of the frontal cortex in OSAS. Lezak
et al. (11) deﬁne executive functions as a person’s
ability to respond in an adaptive manner to
situations and to engage successfully in independ-
ent, purposive and self-serving behavior, which is
the basis for many cognitive, social and emotional
skills. According to Beebe and Gozal (10) executive
functions in OSAS can manifest as deﬁcits in
behavioral inhibition, set-shifting, self-regulation
of affect and arousal, working memory, analysis/
synthesis, and contextual memory. Although cog-
nitive deﬁcits can, in most cases, be improved by
continuous positive airway pressure (CPAP) ther-
apy, some deﬁcits in executive function may remain
(2, 8, 10). Persistent deﬁcits raise the possibility of
permanent brain alterations (8–10). Beebe and
Gozal (10) have presented a model linking sleep
disruption, hypoxemia and dysfunction of the
frontal cortex. The model proposes that sleep
disruption and nocturnal hypoxemia and hyper-
carbia reduce the efﬁcacy of sleep-related restorat-
ive processes. This induces a variety of biochemical
and cellular stresses and leads to disruption of the
functional homeostasis and altered neuronal and
glial viability within certain brain areas. The model
suggests that these biochemical and cellular events
are primarily manifested in dysfunction of frontal
regions on the brain cortex. Furthermore, it is
important to notice that executive dysfunction may
also result from injury to other brain regions than
the frontal cortex (11). Frontal lobes have dense
connections to other cortical lobes and to subcor-
tical brain areas. Thus, frontal lobe dysfunction
may also result from damage to these connections.
In OSAS patients executive dysfunctions are
usually mild and they manifest in more demanding
activities, such as social relations, traﬃc, and job
tasks (10). Therefore, executive functions must
always be assessed as a part of a neuropsycholog-
ical evaluation. In OSAS patients the evaluation of
executive skills is even more critical than the
evaluation of basic cognitive skills (e.g. vocabu-
lary) or skills that only partially reﬂect executive
issues (e.g. intelligence tests) (10). Executive func-
tions are not usually impaired across the board,
but some executive functions are impaired while
others are not (12). Therefore, the neuropsycho-
logical assessment must comprise several domains
of executive functions so that any impairments and
their nature can be detected and analyzed. Among
the studies reviewed, Decary et al. (4) and Beebe
and Gozal (10) have proposed recommendations
on which executive functions and which tests
should be included in the neuropsychological
assessment of OSAS patients. An overview of
these recommendations is presented in Table 1.
The psychometric values (e.g. test–retest reliability,
inter-item consistency and interrater reliability) of
these tests as a guide to test choice are limited
because these tests often measure abilities such as
Table 1 Overview of methods recommended for the assessment of executive functions in OSAS by Decary et al. (4) and Beebe and Gozal (10)
Test method Domain of executive function
Wisconsin Card Sorting Test (13) Mental set shifting (4, 10) and abstract behavior (4)
Trails B of Trail Making Test (14) Mental set shifting (4, 10) and abstract behavior (4)
Trail Making Test (14) Conceptual and visuomotor tracking (4)
Mazes (WISC-III; 71) Planning and foresight (4)
Stroop test (15) Focal attention, shifting processes (4) and behavioral inhibition (4, 10)
Copy of Rey-Osterreith Complex Figure (64) Organizational skills/analysis-synthesis on the spatial domain (4, 10)
Fluency tasks (11) Analysis/synthesis (10)
Back digit strings (WAIS-R; 65) Working memory (10)
Visual sequences (11) Working memory (10)
N-back test (11) Working memory (10)
Behavior Rating Inventory of Executive Functioning (72) Self-regulation of affect and arousal (10)
WISC-III, Wechsler Intelligence Scale for Children – Third Edition; WAIS-R: Wechsler Adult Intelligence Scale-Revised.
Saunama¨ki & Jehkonen
2
response to novelty or strategy formation, which
are one-shot tests (12). Most of the tests also allow
for retesting (Table 1), bearing in mind the impact
of learning effect. Particularly high learning effects
(4) have been reported in the Wisconsin Card
Sorting Test (WCST) (13), the Trail Making Test
(TMT) (14), and the Stroop Test (15). According
to Burgess (12) the use of a wide battery of
executive tests helps to overcome the problem that
there is no common agreement about the aspects of
executive skills that are actually measured in the
most widely used neuropsychological tests or about
the extent to which they are indicators of real-
world impairment. The use of a wide variety of
tests provides for greater coverage of many differ-
ent functions. The disadvantage of this approach is
that it increases the likelihood of false-positive
results.
Our review oﬀers a systematic update on recent
research ﬁndings over the past 15 years (from
January 1990 to December 2005) concerning exe-
cutive functions in OSAS. We wanted to focus on
how executive functions have been assessed in
OSAS, with special emphasis on the following
aspects: (i) what generalizations can be made from
previous studies based on the number of subjects,
the presence of a control group, severity of OSAS,
and other main background variables, (ii) what
tests have been used to assess executive functions,
(iii) what domains of executive functions are
diﬀerent tests thought to measure, (iv) which
executive functions are most frequently defected,
and (v) what impacts does CPAP treatment have
on executive functions?
Materials and methods
Main terms used in the search
Obstructive sleep apnea syndrome is described in
the literature by a variety of concepts: obstructive
sleep apnea (OSA), OSAS, obstructive sleep apnea-
hypopnea syndrome (OSAHS), sleep apnea-hypop-
nea syndrome (SAHS) and obstructive sleep-dis-
ordered breathing. The term that appears most
frequently is obstructive sleep apnea, which is
what we decided to use in our search. Instead of
executive functions, we used the broader terms of
cognitive or neuropsychological in order to
identify as many studies as possible that were at
least partially concerned with executive functions.
Selection of the articles
The ﬁrst step was to search the Cochrane Library
database to see whether there were any recent or
ongoing reviews on this subject, but we found
none. We searched MEDLINE and PSYCHLIT
for articles published between January 1990 and
December 2005. The search was carried out using
the terms obstructive sleep apnea and cognitive or
obstructive sleep apnea and neuropsychological. We
found a total of 196 articles. The exclusion criteria
were: (i) non-English articles, (ii) studies of non-
human, and (iii) non-adult subjects (<19 years).
There now remained 107 articles. Next, we
excluded case reports, reviews, experimental
studies, letters, commentaries, abstracts, and chap-
ters of edited volumes. This left us with 47 articles.
The full articles of these 47 studies were reviewed.
Studies that were exclusively concerned with other
aspects of cognition than executive functions were
excluded. All studies that reported the results of
even one executive function were included. This
criterion was met by 24 of the 47 articles. The lists
of references of these 24 studies were searched; this
yielded 16 additional articles. The total number of
articles reviewed for this study was thus 40.
Results
Demographic and clinical data
The number of the patients in our review ranged
from 8 to 199 (median: 24). In one case (16) it was
not possible to establish the number of patients, as
this was a population-based study and the number
of healthy controls and the number in the patient
group were not differentiated. The mean age of
patients ranged from 40 to 65 years (median:
49 years). Three studies (16–18) did not report
the mean age for the patient group. Education in
years ranged from 9 to 15 (median: 13 years).
Education was not speciﬁed in 19 studies (18–36)
and in ﬁve studies education was reported as a
categorical variable (16, 17, 37–39). The propor-
tion of men in the study samples ranged from 47%
to 100%. In 83% of the studies the patient group
consisted mainly (‡75%) of men. Two studies (20,
40) did not specify the gender of their patients.
Furthermore, two studies (16, 17) reported gender
only for the whole group, without specifying the
gender breakdown for the patient group.
The severity of sleep apnea in the patient groups
was reported in 39 studies. One study (16) reported
the severity of sleep-disordered breathing only for
the total group. If the severity of sleep apnea was
not clearly deﬁned, it was categorized on the basis
of the range of obstructive breathing events per
hour (mild: from 5 to 15 events, moderate: from 15
to 30, and severe: >30). Homogeneous patient
groups with mild sleep apnea were studied in ﬁve
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studies (18, 26, 31, 41, 42) and with severe sleep
apnea in four studies (24, 36, 43, 44). The rest of
the studies comprise heterogeneous patient groups
in terms of the severity of OSAS. Patients with
moderate to severe sleep apnea were studied in 14
studies (19, 20, 23, 27, 28, 30, 32, 33, 35, 45–49) and
with mild to severe sleep apnea in 13 studies (17,
21, 22, 29, 37–40, 50–54). For three studies (25, 34,
55) it was not possible to establish the range of the
severity of OSAS.
Patient selection
A selected group of patients was recruited in 29 of
the 40 studies (18–20, 24, 25, 28, 30, 31, 33–38, 41–
55). In nine studies the patient sample was drawn
from consecutive cases (21–23, 26, 27, 29, 32, 39,
40). Two were population-based studies using
consecutive samples (16, 17).
Description of the control groups
A control group was included in 31 studies. The
OSAS patients performance was compared with
healthy controls in 15 studies (17, 23, 27, 30, 35, 36,
41–43, 45, 47, 49–52). In nine of these studies (17,
35, 41, 43, 45, 47, 49, 51, 52) the controls
healthiness was ensured by polysomnographical
measurement and in six studies (23, 27, 30, 36, 42,
50) with the exclusion criteria of no evidence of
sleep disorder based on an interview and/or on a
physical examination and/or on sleepiness scales.
In six studies the OSAS patients performance was
compared with other patient group(s): patients
with multi-infarct dementia, patients with mild to
moderate dementia of Alzheimer type and patients
with severe chronic obstructive pulmonary disease
(COPD) (40), COPD patients only (55), patients
with carbon monoxide poisoning (44), heavy non-
apnetic snorers (46), and insomniacs (48, 54).
In 10 CPAP treatment eﬃciency studies, OSAS
patients with eﬀective CPAP were compared with
OSAS patients receiving other treatment: placebo
treatment by tablet (18, 22, 26, 28, 31), placebo
treatment by ineffective CPAP (33, 34), or conser-
vative treatment (20, 37). In one of these 10 studies
the efﬁciency of auto-CPAP was compared with
constant-CPAP (25).
Assessment of executive functions
The neuropsychological tests used most often for
the measurement of executive functions in our
review are listed in Table 2. Table 2 also describes
which domains of executive functions the tests are
thought to measure and how many studies repor-
ted the results of these tests. Nine studies (17, 22,
26, 28, 37, 45, 47, 51, 55) used only version B of the
TMT and two studies (38, 41) used only the Digit
Span backwards. Some studies also used less
common tests that according to the authors are
sensitive to frontal lobe and executive dysfunction:
the Verbal Analogy Test (56), which measures
verbal intelligence and deductive thinking (40);
Generating an optimal telegram task (57), which
measures the efﬁciency of logical reasoning (54);
the Category test (11), which measures abstract
thinking and mental ﬂexibility (55); the Digit
Symbol Substitution Task computerized version
from the revised Wechsler Adult Intelligence Scale
(58), which measures processing speed, coordina-
tion, and working memory (35); the 2-back verbal
working memory task (11), which measures work-
ing memory (36); the Park and Holzman’s proce-
dure (59), which measures spatial working memory
(51); and the Mental control from the Wechsler
Memory Scale (60), which measures simple track-
ing (55). In addition, the following four tests were
used without specifying any particular domain of
executive function: the Temporal Rule Induction
(40, 61), the D2 test (52, 62), the Five-Point Test
(11, 49), and the Serial subtraction task (11, 41,
51).
Table 3 shows the number of tests measuring
executive functions in each study. Twenty studies
used only one or two tests to assess executive
functions. Most treatment efﬁciency studies used
the same executive tests for purposes of retesting
(18, 20, 21, 22, 25, 26, 28, 31, 32, 36, 37, 39, 44). Six
studies (27, 30, 33, 34, 43, 47) used partly or totally
alternative or parallel versions of the tests.
OSAS patients pre-treatment performance compared with
healthy controls in the executive functions
Obstructive sleep apnea syndrome patients pre-
treatment performance was compared with
healthy controls to identify the executive tests in
which the patients performance was most often
defected (Table 4). Impaired test performances
were found most frequently in the Digit Span
forwards and backwards (23, 27, 41, 49, 52), in
the Corsi’s block-tapping test (23, 27), in the
phonological ﬂuency task (43, 45, 47, 50), in the
copy of the Rey-Osterreith Complex Figure Test
(ROCFT) (43, 45, 47, 52), in the Mazes test (45,
47, 52), and in the perseverative errors of the
WCST (23, 27, 41, 51). The Double encoding task
(23, 27), the 2-back test (36) and the Raven’s
progressive matrices (43) were rarely used, but




Impact of the CPAP treatment on executive test performance
Nineteen of the 40 studies included an evaluation
of treatment eﬃciency (18, 20, 22, 24, 25–28, 30–
34, 36, 37, 39, 43, 44, 47). Most of these studies
(89%) used CPAP treatment (18, 20, 22, 24, 25–28,
30–34, 36, 43, 44, 47). Both CPAP and uvulopa-
latopharyngopalsty surgery (UPPP) were used in
one study (37). In one study (39) UPPP was used as
the only method of treatment.
Minimum CPAP treatment time in the 18 studies
ranged from 1 week to 12 months (median:
8 weeks). Fifteen studies (18, 20, 22, 25–28, 30–
34, 36, 44, 47, 51) conducted one follow-up, and
three studies (24, 37, 43) conducted two follow-ups.
Table 2 The most commonly used tests for assessing executive functions in OSAS patients
Test method Domain of executive function No. of studies using the test
Fluency tasks (11) of which: 24
(a) Phonological Language (40, 53) 21
Cognition (18)
Planning abilities (40)
Verbal cognitive speed and ability to retrieve words from lexical memory (17)
Verbal fluency/production ability (22, 26, 28, 43, 45, 47)
Not specified (16, 23, 27, 30, 33, 34, 38, 44, 50–52)
(b) Semantic Conceptual semantic knowledge (40) 3
Language (53)
Not specified (50)
Trail Making Test: Trails A and B (14) Cognitive set shifting and flexibility (43, 49) 20
Attentional capacity (23, 27, 30)
Visuomotor activity and visual search (49)
Processing speed (53)
General cognitive function (18, 20)
Not specified (19, 21, 25, 29, 31–34, 38, 41, 44, 52, 53)
Digit Span forwards and backwards (65) Short-term, immediate memory (23, 27, 30, 43, 55) 14
Working memory (23, 30, 42, 43, 49, 51, 53)
Memory efficiency (27, 30)
Central executive memory (49)
Attention (42, 52)
Not specified (24, 33, 34, 44)
Wisconsin Card Sorting Test (13) Abstract reasoning ability (39) 11
Contextual flexibility, shifting (39, 42)
Not specified (23, 27, 30, 38, 41, 50–53)
Stroop test (15) Attentional capacity (18, 23, 27, 30, 46, 48) 9
Inhibition (43, 46, 48)
Not specified (23, 49)
Tower tests (11) Not specified (23, 27, 30, 51, 53) 5
Copy of Rey-Osterreith Complex Figure Test (64) Perceptual organization (42) 5
Visuo-constructional abilities (43)
Not specified (45, 47, 52)
Corsi's block-tapping test (11) Short-term memory (23, 27, 30, 43) 5
Working memory (23, 30)
Memory efficiency (27)
Visual attention (42)
Raven's progressive or colored matrices (66, 67) Nonverbal reasoning (43) 4
Reasoning in visuospatial modality (40, 46, 48)
Mazes tests (11) Planning and problem solving (54) 4
Not specified (45, 47, 52)
Double encoding task (e.g. 23) Short-term memory (23, 27, 30) 3
Working memory (23, 30)
Memory efficiency (27, 30)
Twenty questions procedure (68) Strategy formation in verbal problem-solving (23, 27, 30) 3
Table 3 Number of neuropsychological tests assessing executive functions in
the studies reviewed
No. of test(s) in each study No. of studies
One test 13 (16, 19–21, 24, 25, 29, 31, 32, 36, 37, 39, 40)*
Two tests 7 (17, 22, 26, 28, 46, 48, 54)
Three tests 4 (18, 34, 44, 50)
Four tests 9 (33, 38, 40–42, 45, 47, 49, 55)
Five tests 0
Six tests 1 (53)
Seven tests 2 (51, 52)
Eight tests 1 (43)
Nine tests 3 (23, 27, 30)
*Numbers in parentheses refer to the original articles reviewed.
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In 12 studies (18, 20, 22, 25, 26, 28, 30–34, 43)
compliance to therapy ranged from 3.2 to 6.5 h per
night (median: 5.3 h). Two studies (36, 37) repor-
ted only the minimum demanded using hours per
night. Four studies (24, 27, 44, 47) did not specify
compliance.
Among the studies measuring CPAP treatment
eﬃciency ﬁve (27, 30, 36, 43, 47) included a healthy
control group at the baseline evaluation. In nine
studies the control group consisted of OSAS
patients: in seven of them (18, 22, 26, 28, 31–33)
the control group used placebo treatment and in
the other two (20, 37) conservative treatment. Two
studies (24, 32) did not have a control group. One
study (44) used a group of patients with carbon
monoxide poisoning as a control group at the
baseline evaluation. In one study (25) auto-CPAP
was compared with constant-CPAP.
The impact of CPAP treatment on executive
functions in the ﬁve studies (27, 30, 36, 43, 47)
including a healthy control group is described in
Table 5. CPAP treatment improved efﬁciently
performance time in the Stroop test (27, 30),
decreased perseverative errors in the WCST (27,
30) and improved performance in the Mazes test
(47). Improvement was also seen in one (47) of the
two studies using the copy of the ROCFT. None of
these studies included a healthy control group in
the follow-up phase.


























Digit-f + o + + na o +* na o* na na na
Digit-b + o + o + o +* na o* na na na
Corsi + na + na na o na na o na na na
DET + na + na na na na na na na na na
2-back na na na na na na na na na na na +
TMT-A o o o o o o na na na na na na
TMT-B o o o o o o o na o + + na
Stroop-t + na + o na o na na na na na na
Stroop-e na na na o na + na na na na na na
WCST-c + o o na na na + o na na na na
WCST-e + + + na + na o o na na na na
Tower + o o na na na na na na na na na
TQP o na o na na na na na na na na na
Fluency-p o na o na na + o + na + + na
Fluency-s na + na na na o na o na na na na
ROCFT na na na na na + + na o + + na
Raven na na na na na + na na na na na na
Mazes na na na na na na + na na + + na
Digit-f, the Digit Span forwards; Digit-b, the Digit Span backwards; Corsi, the Corsi's block-tapping test; DET, the Double encoding task; 2-back, the 2-back verbal working
memory task; TMT-A, the Trail Making Test, Trails A; TMT-B, the Trail Making Test, Trails B; Stroop-t, performance time in the Stroop test; Stroop-e, errors in the Stroop test;
WCST-c, categories achieved in the Wisconsin Card Sorting Test; WCST-e, perseverative errors in the Wisconsin Card Sorting Test; Tower, the Tower tests; TQP, the Twenty
questions procedure; Fluency-p, the Phonological fluency tasks; Fluency-s, the Semantic fluency tasks; ROCFT, the copy of the Rey-Osterreith Complex Figure Test; Raven, the
Raven's Progressive Matrices; Mazes, the Mazes Tests. + indicates impairment between OSAS patients and healthy control group; o indicates no difference between OSAS
patients and healthy control group; na indicates that the cognitive domain was not assessed in the study.
*In the studies by Laakso et al. (42) and Rouleau et al. (52) the Digit Span was reported as a sum of the Digit Span forwards and backwards.
Table 5 Impact of CPAP treatment on executive test performance in studies

















Digit-f o x o na na
Digit-b o x o na na
Corsi o x o na na
DET o na o na na
2-back na na na na o
TMT-B x x x o na
Stroop-t + x + na na
Stroop-e na o na na na
WCST-c x na o na na
WCST-e + na + na na
Fluency-p x o x o na
ROCFT na o na + na
Raven na o na na na
Mazes na na na + na
Digit-f, the Digit Span forwards; Digit-b, the Digit Span backwards; Corsi, the
Corsi's block-tapping test; DET, the Double encoding task; 2-back, the 2-back
verbal working memory task; TMT-B, the Trail Making Test, Trails B; Stroop-t,
performance time in the Stroop test; Stroop-e, errors in the Stroop test; WCST-c,
categories achieved in the Wisconsin Card Sorting Test; WCST-e, perseverative
errors in the Wisconsin Card Sorting Test; Fluency-p, the Phonological fluency
tasks; ROCFT, the copy of the Rey-Osterreith Complex Figure Test; Raven, the
Raven's progressive matrices; Mazes, the Mazes Tests. x indicates that per-
formance in the test was not impaired pre-treatment; + indicates improvement
with CPAP treatment; o indicates no change in test performance with CPAP




In the studies (18, 20, 22, 25, 26, 28, 31, 33, 34,
37) that compared the performance of OSAS
patients receiving CPAP treatment with patients
receiving placebo or conservative treatment, exe-
cutive functions were assessed with the Digit Span
forwards and backwards, the Trails A and B, the
Stroop test, and the phonological ﬂuency task.
Improvement was usually seen in executive test
performance, but only three studies reported sig-
niﬁcantly better improvement with CPAP than
with placebo or conservative treatment: this was in
two (22, 26) of nine studies using the Trails B, and
in one (18) of six studies using the phonological
ﬂuency task.
Discussion
This review provides an update on recent research
ﬁndings concerning executive functions in OSAS,
with special emphasis on the following aspects: the
generalizability of former studies based on patient
characteristics and the presence of a control group,
the methods used in assessing executive functions,
the domains of executive functions that diﬀerent
tests are thought to measure, the executive func-
tions that are most often defected, and the possible
eﬀect of CPAP treatment on executive functions.
The sample size in the studies reviewed ranged
from 8 to 199 (median: 24). Among the 40 studies
19 had less than 24 patients. This wide variability
in sample sizes very much undermines the com-
parability of the diﬀerent studies as well as the
statistical analysis of the results. The mean age of
patients ranged from 40 to 65 years, representing
the population of working age which is an
important target group for neuropsychological
assessment. Most of the studies (73%) recruited
heterogeneous patient groups consisting of selected
samples. Only half of the studies speciﬁed the
patients educational level, even though this is
usually thought to be one of the most important
background variables aﬀecting cognitive test per-
formance. In the studies reviewed the patient
samples consisted primarily of men, but it is
important to note that the estimated prevalence
of OSAS in females is up to 2% (63). Twenty-ﬁve
percent of the studies reviewed had homogeneous
patient groups in terms of the severity of OSAS,
which can signiﬁcantly affect the appearance of
executive dysfunction. In the studies that involved
heterogeneous patient groups with patients from
mild to severe OSAS, the mean number of
obstructive breathing events is not informative
enough as a single measure of OSAS severity. The
range of obstructive breathing events and the
number of patients in different severity groups
should therefore be reported in detail. To conclude,
the generalizability of the studies reviewed is
undermined by the variation in sample sizes, the
heterogeneity of patient groups, the overrepresen-
tation of male patients, inadequate reporting on
education, and inaccuracies in deﬁning the severity
of OSAS.
A control group was used in 31 of the 40 studies:
a healthy control group was used in 15 studies,
other patient groups in six studies (patients with
multi-infarct dementia or dementia of Alzheimer
type, patients with COPD, patients with carbon
monoxide poisoning, heavy non-apnetic snorers,
and insomniacs), and in 10 studies OSAS patients
receiving CPAP treatment were compared with
OSAS patients receiving placebo or conservative
treatment. As Aloia et al. (8) have pointed out, the
use of a control group is scientiﬁcally more
rigorous than the use of normative comparisons.
In our review, we analyzed the pre-treatment
executive function of OSAS patients in comparison
with a healthy control group, because we wanted to
evaluate the nature of executive dysfunction in
OSAS patients compared with the healthy popula-
tion. It is misleading to compare executive func-
tions in OSAS patients with other patient groups as
cognitive defects are common sequelae in patients
suffering from dementia, COPD or carbon mon-
oxide poisoning, for example. The healthy control
group should be matched to the patient group at
least according to age, gender and education, and
the healthiness of the control group should be
assessed by polysomnographic measurement as
even asymptomatic healthy volunteers can suffer
from mild obstructive breathing events. In our
ongoing study a signiﬁcant number of healthy
controls have had to be excluded after polysom-
nography ﬁndings, even though they reported
being asymptomatic in the screening interview.
The test methods that were used most often for
evaluating executive functions in the studies
reviewed were partly the same as those recommen-
ded by Decary et al. (4) and Beebe and Gozal (10):
the WCST (13), the TMT (14), the Stroop test (15),
the copy of the ROCFT (64), the Mazes tests
(11), the ﬂuency tasks (11), the Digit strings (Digit
Span forwards and backwards; 65), and the Visual
sequences (the Corsi’s block-tapping test; 11). In
addition, the Tower tests (11), the Raven’s matrices
(66, 67), the Twenty questions procedure (68), and
the Double encoding task (23) were also used in the
studies reviewed to assess executive functions.
Some studies furthermore used less common tests
to assess executive dysfunction. In some studies the
authors failed to specify what particular domain of
executive function they wanted to measure with a
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single test, but they set about assessing executive
function as a single global function. This may lead
to the false conclusion that executive function
per se is totally impaired or totally intact. Even in
the most commonly used executive tests there were
diﬀering uses as to what the test was thought to
measure. Some authors (18, 53) suggested that the
test (e.g. the ﬂuency tasks and the copy of the
ROCFT) was an assessment of a basic cognitive
skill, others (23, 42, 51) thought the same test
evaluated executive functions. The Digit Spans and
the Corsi’s block-tapping test were in most cases
thought to assess short-term and working memory,
but also attention. The TMT was conducted as a
method of attention, processing speed, visuomotor
function and cognitive ﬂexibility. The Stroop Test
was used to measure both attention and inhibition.
The ROCFT and the Raven’s matrices were seen as
test methods of executive function from a visual
point of view while the Twenty question procedure
was considered to evaluate executive function from
a verbal perspective. Studies using the WCST, the
Tower tests, and the Mazes tests did not normally
specify the domain of executive function. Half of
the studies used only one or two methods for
assessing executive functions. However, this does
not provide a sufﬁciently sound basis for drawing
conclusions and it is possible that neuropsycho-
logical assessment fails to detect dysfunction in
some important domains of executive functions
that may still have a negative inﬂuence on the
OSAS patient’s daily performance. This variability
in the testing of executive functions and in the
domains they are thought to measure very much
complicates the interpretation of the results and
undermines their comparability.
Some studies concluded that neuropsychological
tests are not sensitive enough to detect mild
executive or other cognitive dysfunction (37, 51)
and that this is most evident in patients with high
general intelligence (37). According to Alchanatis
et al. (69) high intelligence may have a protective
effect against OSAS-related cognitive decline; cog-
nitive reserve and a high level cognitive functioning
can compensate for both hypoxic brain dysfunc-
tion and daytime somnolence. According to Ver-
straeten et al. (49) it is always necessary to control
for attentional capacity when assessing executive
function. They report that OSAS patients suffer
from sleepiness-related vigilance and attention
deﬁcits, but not speciﬁc hypoxemic-related execu-
tive attentional problems. They make the critical
comment that many former studies have attributed
attentional problems to executive deﬁcits because
they have failed to control for attentional capacity.
This means that when executive function is
assessed by means of the Trails B, for example,
attention capacity should always be controlled
with the Trails A; and when working memory is
assessed with the Digit Span backwards, memory
span should ﬁrst be controlled with the Digit Span
forwards.
Twelve studies (23, 27, 36, 41–43, 45, 47, 49–52)
compared executive functions in OSAS patients
with healthy controls. All these studies used a
sufﬁcient combination of executive tests (from
three to nine tests), except one study (36) which
included only one executive task. The most fre-
quently defected performances were found in the
Digit Span forwards and backwards, in the Corsi’s
block-tapping test, in the phonological ﬂuency
tasks, in the copy of the ROCFT, in the Mazes
tests, and in the WCST. The domains of executive
function impaired most often were working
memory, phonological ﬂuency, cognitive ﬂexibility,
and planning (especially its non-verbal aspect).
In the ﬁve studies (27, 30, 36, 43, 47) where
OSAS patients performance was compared with
healthy controls at baseline only, CPAP treatment
improved cognitive ﬂexibility and speed, and also
planning in non-verbal tests. It should be noted
that none of these studies used a control group at
follow-up phase to control for the learning effect,
although most of them (four out of ﬁve; 27, 30, 43,
47) did use an alternative or parallel version of the
tests for this purpose. The studies in which learning
effect was controlled with OSAS patients having
placebo or conservative treatment, used only two
or three tests to assess executive functions. In these
studies cognitive performance generally improved,
but the improvement with CPAP treatment was
signiﬁcantly better than with placebo or conserva-
tive treatment in only three (18, 22, 26) out of nine
studies (18, 20, 22, 26, 28, 31, 33, 34, 37). In order
to establish the true effects of CPAP treatment it is
important to control for the learning effect of the
tests. To conclude, the deﬁcits of working memory
persisted after CPAP treatment, and only one
study reported an improvement in phonological
ﬂuency.
We are currently working in an ongoing study to
explore the quantity and quality of executive
dysfunction in OSAS patients compared with
healthy controls and to assess the impact of
CPAP treatment on executive functions. We use a
comprehensive battery of executive tests to assess
diﬀerent domains of executive function, both
paper-and-pencil tasks and computer-assisted
tests (CANTAB; 70). Evaluations of general intel-
lectual ability are also included. A healthy control




Our review and the preliminary ﬁndings of our
ongoing study suggest several recommendations
for further research. First, more attention should
be paid to the number of subjects, to the
background variables that may aﬀect cognitive
performance, and to having an adequate control
group. The number of subjects in studies con-
cerning neuropsychological deﬁcits in OSAS
should be large enough for statistical analyses,
the severity of OSAS in the patient group should
be reported in detail, the healthiness of healthy
controls should be ensured with polysomnogra-
phy, and the learning eﬀect on executive test
performance should be controlled in treatment
eﬃciency studies either with a healthy control
group both at baseline and the follow-up, or with
a control group of OSAS patients receiving
placebo or conservative treatment. Second, for
purposes of assessing executive functions in
OSAS patients it is necessary to create a com-
prehensive test battery using the most common
executive tests (4, 10) so that different domains
of executive function can be measured. In addi-
tion to neuropsychological tests, self-assessing
inventories and a structured interview of patients
and their relatives are needed in order that any
executive dysfunctions can be detected. Third, it
is essential that cognitive and especially executive
function in OSAS patients is assessed when they
have a reduced capacity for working or driving.
Fourth, more research and discussion are needed
on the impact of CPAP treatment on executive
functions, as there are only a few treatment
efﬁciency studies that control for the learning
effect.
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 Introduction 
 Obstructive sleep apnea syndrome (OSAS) is a com-
mon condition  [1] characterized by repetitive episodes of 
complete (apnea) or partial (hypopnea) obstruction of the 
upper airway during sleep, resulting in oxygen desatura-
tion and arousal from sleep  [2] . OSAS is also associated 
with cognitive changes. Among the cognitive domains 
most affected is executive function  [3–7] . 
 Executive functions refer to a person’s ability to re-
spond in an adaptive manner to situations and to engage 
successfully in independent, purposive and self-serving 
behavior, which is the basis for many cognitive, social and 
emotional skills  [8] . According to Beebe and Gozal  [9] , 
executive functions in the context of OSAS can be divided 
into 6 domains: behavioral inhibition, set-shifting, self-
regulation of affect and arousal, working memory, analy-
sis/synthesis and contextual memory. Executive dysfunc-
tion is caused by abnormalities in the frontal cortex or in 
the dense connections between the frontal cortex and oth-
er cortical or subcortical areas  [8] . Beebe and Gozal  [9] 
hypothesize that executive functions are easily disturbed 
in OSAS because nocturnal hypoxemia, hypercarbia and 
sleep disruption reduce the efficacy of sleep-related re-
storative processes, and this induces biochemical and cel-
lular alterations, especially in the frontal cortex. However, 
Verstraeten and co-workers  [10–12] point out that earlier 
studies  [13, 14] did not adequately take into account the 
effects of decreased alertness, and therefore their findings 
 Key Words 
 Cognition   Executive function   Frontal lobes   Obstructive 
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 Abstract 
 Aims: To clarify whether patients with obstructive sleep ap-
nea syndrome (OSAS) have executive dysfunction, to iden-
tify the domains of executive function affected and to estab-
lish the severity of any dysfunction.  Methods: A full-night 
polysomnography and a comprehensive neuropsychologi-
cal assessment focusing on executive functions were con-
ducted on 40 newly diagnosed OSAS patients and 20 healthy 
controls. The severity of dysfunction was analyzed using 
norm-referenced data.  Results: All patients and controls 
were men. The groups did not differ statistically significantly 
in terms of age, education or intelligence quotient. Patients 
showed poorer performance than controls on the copy of the 
Rey-Osterrieth Complex Figure test, the Block Design, the 
Trails B of the Trail Making Test and the Intra-Extra Dimen-
sional Set Shifting test. Based on the normative data, most 
OSAS patients performed at a normal level, but a few pa-
tients had either mild dysfunction (2.5–12.5%) or moderate 
to severe dysfunction (5–15%).  Conclusions: OSAS patients 
have lower set-shifting and analysis/synthesis performance 
than healthy controls. According to the normative data, most 
patients in the present study had normal performance, but 
there were also a few patients with more serious deficits. 
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of executive dysfunction in OSAS remain tentative. They 
conclude that executive deficits in OSAS may be explained 
by reference to attentional capacity deficits, slowed infor-
mation processing and decreased short-term memory 
span, and that these cognitive changes may be explained 
by basal slowing due to sleepiness  [10–12] . 
 Many previous studies have assessed OSAS patients’ 
executive functions with only 1 or 2 tests; this is not 
enough to draw generalizable conclusions about execu-
tive functions in OSAS  [15] . Only a few previous studies 
have assessed executive functions more comprehensively 
 [16–21] . To clarify the nature of executive dysfunction in 
OSAS, it is necessary to evaluate different domains. In a 
recent meta-analysis of studies in OSAS patients  [5] , the 
domain of executive functioning displayed a moderate to 
large mean effect size, indicating substantial executive 
dysfunction in OSAS. Effects sizes with control-refer-
enced data were larger than with norm-referenced data 
 [5] . The use of both control- and norm-referenced data in 
analyzing executive functions in OSAS could help us bet-
ter understand the quantity of these problems. It is also 
important to consider the significance of executive dys-
function in OSAS patients’ daily life  [22] , because pa-
tients often report initiative problems and changes in 
work efficiency in particular.
 To explore executive functions in OSAS in closer de-
tail, we set out in this study to determine (1) whether 
OSAS patients have executive dysfunction compared to 
healthy controls, (2) which, if any, domains of executive 
function are affected and (3) the severity of any changes 
observed based on norm-referenced data.
 Subjects and Methods 
 Subjects 
 The study was conducted in a sleep unit of a university hospi-
tal. Patients were referred to the unit because of possible OSAS. 
The sample included 40 newly diagnosed OSAS patients who met 
the diagnostic criteria and had not had any previous treatment. 
The control group consisted of 20 healthy volunteers. 
 Both the patients and controls were first interviewed by tele-
phone to make sure they met the initial eligibility criteria, i.e., (1) 
age between 20 and 65 years, (2) right-handedness, (3) no (other) 
sleep disorders, (4) no clinically significant medical disorder (e.g., 
neurological illness, psychiatric disorder, hypo-/hyperthyroidism 
or lung diseases other than currently asymptomatic asthma), (5) no 
medication affecting the central nervous system, (6) no substance 
abuse or alcohol abuse based on their own report using the criteria 
of the World Health Organization for alcohol units and (7) no self-
reported primary perception disorder. The patients’ OSAS diagno-
sis and the controls’ healthiness were then confirmed by means of 
a clinical interview and a diagnostic full-night polysomnography 
in a sleep laboratory. The diagnosis of OSAS was based on a clinical 
picture and subjective complaints of OSAS  [2] and on an apnea/hy-
popnea index (AHI)  1 10 per hour of sleep. The controls had to be 
asymptomatic and have an AHI of  ^  5 per hour of sleep. The study 
protocol was approved by the Hospital District Ethical Committee. 
 The subjects gave their written informed consent.
 Procedure and Measures 
 The patients and controls who met the eligibility criteria ac-
cording to the first-night polysomnography underwent a second 
full-night polysomnography and a neuropsychological assessment 
on the following morning. The recordings for the second of the 2 
diagnostic nights were used in the analyses. Subjective sleepiness 
was evaluated with the Epworth Sleepiness Scale (ESS)  [23] . 
 Polysomnography  
 Subjects retired to bed between 10: 00 and 12: 00 PM according 
to their own habitual bedtimes. Six EEG derivations (Fp1-A2, 
Fp2-A1, C3-A2, C4-A1, O1-A2 and O2-A1), 2 electro-oculogra-
phy channels, submental muscle tonus, electrocardiogram, air-
flow pressure via a nasal transducer, thermistor, thoracoabdomi-
nal respiratory movements and blood oxygen saturation were re-
corded. In addition, transcutaneous carbon dioxide tension, leg 
movements, body position and body movements were recorded. 
The second diagnostic night was classified by 2 independent scor-
ers into the old sleep stages from C3-A2 channels  [24] . Somno-
logica  software (Medcare/Flaga, Iceland) was used for visual 
analyses. The level of agreement between the 2 scorers was 86.0% 
(  = 0.76). Based on the 2 coders’ independent scorings, a consen-
sus classification was developed for use in the statistical analyses. 
AHI was calculated as the number of obstructive apneas and hy-
popneas per hour of sleep. Obstructive apnea was defined as at 
least a 90% reduction in the thermal signal amplitude, whereas 
hypopnea was scored as a respiratory event lasting 10 s or more 
and presenting a nasal pressure signal drop of 50% or more from 
baseline with over 3% desaturation or an arousal  [25] . Micro-
arousals were scored according to the criteria of the American 
Sleep Disorders Association  [26] .
 Neuropsychological Assessment  
 Both patients and controls underwent a neuropsychological 
assessment on the morning after the second night. The assess-
ment was always conducted at the same time. General cognitive 
performance was assessed with a short form  [27] of the Wechsler 
Adult Intelligence Scale-Revised  [28] , which included the follow-
ing subtests: Information, Digit Span, Arithmetics, Similarities, 
Picture Completion, Block Design and Digit  Symbol. The execu-
tive tests ( table 1 ) were chosen for inclusive coverage of the differ-
ent domains of executive functions. 
 Statistical Analyses 
 Mean values, standard deviations and ranges were used as 
descriptive values. Since some of the parameters were not nor-
mally distributed and the sample sizes were small, nonparamet-
ric tests were chosen. The 2 subject groups were compared using 
the Mann-Whitney U test. The significance level was set at 0.05 
for all analyses. All reported p values are based on two-tailed 
tests. 
 To evaluate the severity of a possible dysfunction on tests in 
which the 2 groups differed, norm-referenced analysis was con-
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ducted using the Wechsler Adult Intelligence Scale-Revised man-
ual  [28] , the meta-analysis of Mitrushina et al.  [29] and normative 
data from the Cambridge Neuropsychological Test Automated 
Battery. Performances on the Rey-Osterrieth Complex Figure 
Test  [30] , the Block Design  [28] and the Intra-Extra Dimensional 
Set Shifting (IED; Cambridge Neuropsychological Test Automat-
ed Battery) were corrected for age, and performance on the Trails 
B of the Trail Making Test  [31] was corrected for both age and 
education. In this study, the scores were scaled as follows: Z values 
equal to or smaller than –3 were considered indicative of severe 
deficit; Z values from –2.99 to –2 were indicative of moderate def-
icit, and Z values from –1.99 to –1 were indicative of mild deficit. 
Scores equal to or greater than –0.99 were considered to demon-
strate normal performance.
 Results 
 All patients and controls were men. The patients’ mean 
age was 47  years (range 28–65) and that of the controls 
was 43 years (range 29–63). The mean length of education 
for patients was 13 years (range 5–17), and for controls it 
was 14 years (range 8–17). The groups did not differ sta-
tistically significantly in terms of age or education. The 
patients were sleepier, as assessed with the ESS, and had 
a higher body mass index (BMI) than controls ( table 2 ). 
The patients had mild to severe OSAS with sleep frag-
mentation and hypoxemic episodes. The values for sub-
jective sleepiness, BMI and polysomnographic data are 
presented in  table 2 . 
 The mean intelligence quotient (IQ) for patients was 
111 (range 94–132), and for controls it was 118 (range 
104–137); this difference was nonsignificant. The re-
sults of the executive tests are presented in  table 3 . The 
patients had poorer scores than controls on the copy of 
the Rey-Osterrieth Complex Figure Test, the Block De-
sign, the Trails B of Trail Making Test and the IED levels 
completed. On the IED, all controls performed at the 
optimal level, completing 9 levels, while 8 of the OSAS 
patients showed difficulties and completed only 7 or 8 
levels. The number of errors on the IED did not differ 
significantly between the groups. The severity of execu-
tive dysfunction from these 4 tests is presented in  ta-
ble 4 . Most OSAS patients did not show any deficits on 
these tests based on the normative values, while a few 
patients showed either mild deficits or moderate to se-
vere deficits. Although patients performed worse than 
controls on the Block Design, almost every patient had 
normal normative performance on this test. For 4 of the 
40 patients, test performance was lower on more than 1 
test. 
 The 9 patients who showed moderate to severe deficits 
were compared to the 31 patients who performed at a nor-
mal normative level or who showed only mild deficits 
with regard to age, years of education, ESS, BMI, IQ and 
polysomnographic variables (AHI, arousal index, oxygen 
desaturation index, total sleep time, sleep efficiency as a 
percentage of the total sleep time, percentages of sleep 
stage 1, sleep stage 2, slow wave sleep and rapid eye move-
ment sleep). No statistically significant differences were 
found between these groups.
Table 1. Assessment of executive functions
Domain of executive function Test method
Verbal short-term memory span Digit Span forwards [28]
Verbal working memory Digit Span backwards [28]
Visual short-term memory span Spatial Span1: span length
Visual working memory Spatial Working Memory1: strategy
Verbal fluency semantic: animals [8]
phonological: letters PAS (Finnish version of FAS) [8]
Visuospatial organizational skills copy of the Rey-Osterrieth Complex Figure Test (ROCFT) [30]
Block Design [28]
Visuomotor tracking Digit Symbol [28]
Trails A of Trail Making Test: time [31]
Mental set-shifting Trails B of Trail Making Test: time [31]
Intra-Extra Dimensional Set-Shifting1: stages completed and errors
Planning and problem-solving Stockings of Cambridge1: problems solved in minimum moves
1 Subtest of the Cambridge Neuropsychological Test Automated Battery.
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 Discussion  
 OSAS patients had lower visuospatial organizational 
skills and mental set-shifting performance than controls. 
When performance in these executive domains was com-
pared to the normative data, most OSAS patients showed 
normal performance, but a few patients had either mild-
ly impaired performance or moderate to severe deficits. 
Controls performed otherwise at a normal normative lev-
el, but 20% of them had mildly impaired performance on 
the time-limited mental set-shifting task. 
 Our results regarding the lower visuospatial organiza-
tional skills of OSAS patients are in line with earlier find-
ings  [13, 19, 21] . In contrast, our finding of reduced men-
tal set-shifting performance as measured by the Trails B 
has previously been reported only in a study by Bedard et 
al.  [13] ; most earlier studies reported no change on this 
test  [16–19, 21] . In this study, we controlled for possible 
Table 2. Results of subjective sleepiness, obesity and polysomnographic variables in patients and controls
Patients (n = 40) Controls (n = 20) p value
ESS score 11.583.8 (4–18) 4.582.8 (0–11) <0.001
BMI 30.384.6 (24–41) 24.982.7 (20–30) <0.001
TST 426.9849.8 (325–532) 419.4854.7 (328–527) n.s.
SEI, % 90.386.2 (74–100) 89.687.0 (74–98) n.s.
AHI, n/h 41.0822.8 (10–103) 2.582.1 (0–5) <0.001
ARI, n/h 33.8819.2 (8–100) 13.084.4 (4–23) <0.001
ODI4%, n/h 26.0822.3 (0–88) 0.881.4 (0–6) <0.001
S1, % 6.183.9 (1–23) 6.383.6 (2–16) n.s.
S2, % 68.289.7 (48–85) 60.587.7 (45–72) 0.005
SWS, % 8.287.0 (0–23) 13.886.8 (2–25) 0.005
REM, % 17.685.0 (6–28) 19.484.7 (13–28) n.s.
Values shown are means 8 standard deviations (ranges in parentheses). TST = Total sleep time; SEI = sleep 
efficiency index as a percentage of the total sleep time; ARI = arousal index; ODI4% = oxygen desaturation in-
dex; S1 = sleep stage 1 as a percentage of total sleep time; S2 = sleep stage 2 as a percentage of total sleep time; 
SWS = slow wave sleep as a percentage of total sleep time; REM = rapid eye movement sleep as a percentage of 
total sleep time; n.s. = not significant.
Table 3. Results of executive tests in patients and controls
Patients (n = 40) Controls (n = 20) p value
Digit Span forwards 6.981.6 (4–10) 7.181.9 (4–11) n.s.
Digit Span backwards 6.681.3 (4–10) 6.781.6 (4–10) n.s.
Spatial Span 6.681.4 (3–9) 7.181.4 (5–9) n.s.
Spatial Working Memory 30.686.6 (19–43) 29.586.9 (19–41) n.s.
Semantic fluency 24.885.0 (13–34) 25.684.4 (16–31) n.s.
Phonological fluency 39.7811.2 (18–74) 42.2811.2 (27–59) n.s.
ROCFT 33.682.7 (26–36) 35.181.0 (33–36) 0.041
Block Design 33.288.3 (14–49) 39.188.5 (23–51) 0.021
Digit Symbol 45.4811.6 (25–86) 54.0815.5 (33–88) n.s.
Trails A 31.5813.6 (17–73) 32.0810.6 (14–61) n.s.
Trails B 73.0847.4 (42–238) 61.5832.5 (31–159) 0.019
IED stages 8.680.7 (7–9) 9.080.0 (9) 0.021
IED errors 18.1811.5 (7–45) 13.086.4 (7–28) n.s.
Stockings of Cambridge 9.781.9 (3–12) 9.982.1 (5–12) n.s.
Values shown are means 8 standard deviations (ranges in parentheses). ROCFT = Copy of Rey-Osterrieth 
Complex Figure Test; n.s. = not significant.
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attentional capacity deficit, e.g. slowed information pro-
cessing, by including in the test battery not only an ex-
ecutive subtest (Trails B), but also a subtest that measures 
attentional capacity (Trails A), as Verstraeten and co-
workers  [10–12] have recommended. The groups did not 
differ on Trails A, but on Trails B, the OSAS patients 
showed poorer performance. This suggests that executive 
dysfunction such as decreased mental set-shifting occurs 
in OSAS patients and that it is not explained by slowed 
processing speed only. However, it is noteworthy that 
some of the controls in our study had mildly reduced per-
formance on Trails B based on the normative data. It is 
possible that there is wide variety in performance on this 
test even in the healthy population. 
 Our finding of lower mental set-shifting in OSAS pa-
tients is also supported by their reduced performance on 
the IED. The IED is used to assess similar executive func-
tion to the well-known Wisconsin Card Sorting Test  [32] . 
Earlier studies have reported that OSAS patients have im-
paired mental set-shifting performance as assessed by the 
Wisconsin Card Sorting Test, either in terms of the stag-
es completed  [16, 19] or in the number of perseverative 
errors  [16–18] .
 Our results did not confirm the results of Naëgele et al. 
 [16] and Feuerstein et al.  [17] that OSAS patients have im-
paired working memory. This may be due to the insensi-
tivity of the working memory tasks used in this study. N-
back working memory tasks seem to be more sensitive in 
detecting working memory deficits in OSAS  [33, 34] . In 
addition, our results did not indicate reduced verbal flu-
ency in OSAS patients. Earlier results concerning verbal 
fluency are inconsistent; some studies report impaired 
verbal fluency  [18, 20, 21] , while others do not  [16, 17, 19] . 
Our result of normal performance for planning abilities, 
assessed by the Stockings of Cambridge test, is in line with 
earlier findings  [17, 18] . However, Naëgele et al.  [16] re-
ported partly impaired performance on a Tower test  [8] .
 Based on the model of Beebe and Gozal  [9] , our results 
show that when compared to the control-referenced data, 
executive functions of OSAS patients are partly impaired, 
as are set-shifting and analysis/synthesis performance. 
However, when compared to the norm-referenced data, 
most OSAS patients perform at the normal level and only 
some patients have executive dysfunction. Although pa-
tients with executive dysfunction seem to be a minority, 
it is important to detect these patients because even mild 
executive dysfunction may have a negative impact on pa-
tients’ working ability, and moderate to severe deficits 
may cause definite problems in daily life. These patients 
cannot be detected on the basis of their background data; 
our patients with moderate to severe executive dysfunc-
tion did not differ from those with normal performance 
or only mildly impaired performance in terms of age, ed-
ucation, IQ, ESS, BMI or conventional polysomnograph-
ic variables. It seems obvious that cognitive dysfunction 
in OSAS is a multifactorial phenomenon. Sleepiness, 
sleep fragmentation, hypoxemia and hypercarbia may all 
have an impact on cognitive function  [3, 9, 12, 22] . In ad-
dition, cognitive problems may also be increased by oth-
er OSAS-related health problems like obesity, hyperten-
sion, metabolic syndrome, diabetes and increased risk of 
cerebrocardiac vascular problems  [35] . 
 There is a connection between OSAS and executive 
dysfunction, but it is not possible to draw any conclusion 
about the causality. OSAS may cause cognitive dysfunc-
tion, but it is also possible that prior cognitive dysfunc-
tion can predispose individuals to poor health habits and 
increase the risk of developing OSAS. To the best of our 
knowledge, our patients did not have prior cognitive dys-
function. Because patients are not usually assessed neu-
ropsychologically prior to diagnosis with OSAS, age, edu-
cation and IQ are the variables that can be used to evalu-
ate their premorbid cognitive skills. Thus, one of the 
strengths of our study is that the patients and controls did 
not differ significantly in terms of age, years of education 
or IQ, which adds to the reliability of the results. Older 
age may contribute to poorer cognitive performance be-
cause of higher cerebrovascular risks or additionally dis-
turbed sleep  [36] . By contrast, higher education level and 
Table 4. Severity of executive dysfunction based on Z values in 




(–2 < Z ≤ –1)
Moderate
(–3 < Z ≤ –2)
Severe
(Z ≤–3)
Patients (n = 40)
ROCFT 33 (82.5) 5 (12.5) 1 (2.5) 1 (2.5)
Block Design 39 (97.5) 1 (2.5) – –
Trails B 29 (72.5) 5 (12.5) 1 (2.5) 5 (12.5)
IED stages1 31 (77.5) 5 (12.5) 3 (7.5) –
Controls (n = 20)
ROCFT 20 (100) – – –
Block Design 20 (100) – – –
Trails B 16 (80) 4 (20) – –
IED stages 20 (100) – – –
Values shown are numbers of patients/controls (percentages in 
parentheses). ROCFT = Copy of Rey-Osterrieth Complex Figure 
Test. 
1 One missing value.
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IQ can protect from cognitive changes  [37] . A limitation 
of this study is that the effect of executive dysfunction on 
patients’ daily performance was not investigated in de-
tail. To conclude, not all OSAS patients have executive 
dysfunction but there are some patients who do suffer 
more serious deficits. 
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clusion: Even long-term CPAP treatment does not seem to 
improve OSAS patients’ mental set-shifting performance or 
their  visuospatial organizational skills. In addition, OSAS pa-
tients have impaired learning effect in executive tests. 
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 Introduction 
 Obstructive sleep apnea syndrome (OSAS) is associ-
ated with cognitive changes, especially executive dys-
function  [1, 2] . Beebe and Gozal  [3] argue that executive 
functions may be easily disturbed in OSAS because hy-
poxemia, hypercarbia and sleep disruption reduce sleep-
related restorative processes and cause biochemical and 
cellular alterations especially in the frontal brain areas. 
Executive functions refer to a person’s ability to engage 
successfully in adaptive, independent, purposive and 
self-serving behavior  [4] . Earlier studies have reported 
decreased mental set-shifting performance, visuospatial 
organizational skills  [5–8] , behavioral inhibition  [6, 7, 9] , 
and reduced working memory in OSAS patients  [6, 7, 10, 
11] .
 It seems that executive dysfunction can be partially 
reversed with continuous positive airway pressure
 Key Words 
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Learning effect   Obstructive sleep apnea syndrome 
 Abstract 
 Aims: To assess the impact of continuous positive airway 
pressure (CPAP) treatment on executive dysfunction in pa-
tients with obstructive sleep apnea syndrome (OSAS).  Meth-
ods: At baseline, 20 OSAS patients and 17 healthy controls 
underwent polysomnography and neuropsychological as-
sessment focusing on executive functions. After at least 6 
months of CPAP treatment, the patients returned for one 
more full-night polysomnography and neuropsychological 
control assessment, while the controls underwent a neuro-
psychological control assessment.  Results: All patients and 
controls were working-age males. OSAS severity ranged 
from mild to severe. Before CPAP, patients showed poorer 
performance than controls in the copy of the Rey-Oster-
rieth Complex Figure Test, the Block Design, the Digit Sym-
bol, the Trails B and the Intra-Extra Dimensional Set-Shifting 
task.  Patients’ executive performance showed no improve-
ment after CPAP, and it remained poorer than the perfor-
mance of controls. In addition, patients showed no learning 
effect in the executive tests, whereas the controls did.  Con-
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(CPAP) treatment  [2, 12] . Seven out of the 15 studies re-
viewed by Aloia et al.  [2]  showed improved executive 
function after CPAP treatment. However, the evidence is 
inconsistent; some studies report an improvement in ex-
ecutive domains with CPAP  [5–7] , while others do not  [9] . 
Most placebo-controlled studies report that CPAP does 
not have a greater effect on executive functioning than 
placebo treatment  [13–16] . Only a few studies have shown 
the opposite result  [17–19] . 
 There is then still no consensus on the long-term im-
pact of CPAP on executive dysfunction. The effects of 
CPAP are sensitive to the duration of the treatment and 
to compliance  [20] . In placebo-controlled studies, treat-
ment is usually provided from 1 to 8 weeks, which is not 
necessarily enough to see an improvement in the com-
plex cognitive domain that is executive functioning. 
There are only a few earlier studies that have explored 
OSAS patients’ executive dysfunction in greater depth, 
based on CPAP treatment periods of 4 months or longer 
 [5–7, 9] . 
 In our recent study  [8] , OSAS patients showed lower 
mental set-shifting and visuospatial organizational skills 
than healthy controls. Our focus here is on the impact of 
CPAP treatment on the observed dysfunction after at 
least 6 months of treatment. Furthermore, possible learn-
ing effects in executive tests are investigated using a 
healthy control group at follow-up assessment.
 Subjects and Methods 
 The subjects for this study were drawn from the same set of 
40 patients whose pretreatment executive functioning was inves-
tigated in our recent study  [8] . The inclusion criteria were CPAP 
use at least 4 h per night and at least 5 nights per week over a pe-
riod of 6 months or longer. Twenty patients met the inclusion 
criteria, and 20 patients were excluded from post-treatment fol-
low-up because of inadequate CPAP use. The control group was 
drawn from the same set of 20 healthy controls recruited in our 
recent study. After an interval of at least 6 months, 17 controls 
returned for a neuropsychological control assessment; 3 refused 
to take part.
 Both the patients and controls were first interviewed by tele-
phone to make sure they met the initial eligibility criteria: (a) age 
between 20 and 65 years, (b) right-handedness, (c) no (other) sleep 
disorders, (d) no clinically significant medical disorder (e.g. neu-
rological illness, psychiatric disorder, hypo-/hyperthyroidism or 
other lung diseases than currently asymptomatic asthma), (f) no 
medication affecting central nervous system, (g) no substance 
abuse or alcohol abuse based on their own report using the crite-
ria of WHO for alcohol units, and (h) no self-reported primary 
perception disorder. The patients’ OSAS diagnosis and the con-
trols’ healthiness were then confirmed with a clinical interview 
and diagnostic full-night polysomnography in a sleep laboratory. 
The diagnosis of OSAS was based on a clinical picture and subjec-
tive complaints of OSAS  [21] and on an apnea/hypopnea index 
(AHI)  1 10 per hour of sleep. The controls had to be asymptom-
atic and to have an AHI of  ^  5 per hour of sleep. The study was 
performed in a university hospital and the protocol was approved 
by the Hospital District Ethics Committee. The subjects gave their 
written informed consent.
 Procedure and Measures 
 At baseline, patients and controls who according to the first 
night polysomnography met the eligibility criteria underwent a 
second full-night polysomnography and a neuropsychological as-
sessment focusing on executive functions the following morning. 
The recordings for the latter polysomnography were used in the 
analyses. Subjective sleepiness was evaluated with the Epworth 
Sleepiness Scale  [22] . 
 After at least 6 months of CPAP treatment, patients returned 
for full-night polysomnography (the treatment night) and a neu-
ropsychological control assessment the following morning. Prior 
to the treatment night, objective compliance measures were 
downloaded from CPAP units showing the mean hours per night 
from the past 30 days. In addition, to ensure at least minimum 
compliance for the whole treatment period, the downloadings 
were performed 2–3 times during the treatment at nurse controls. 
The controls underwent a neuropsychological control assessment 
after an interval of at least 6 months from the baseline assessment. 
 Polysomnography 
 The second diagnostic night was classified by 2 independent 
scorers into sleep stages according to the rules presented in the 
manual by Rechtschaffen and Kales  [23] . Visual analyses were 
performed using Somnologica  software (Medcare/Flaga, Ice-
land). Statistical analyses were conducted on the basis of the con-
sensus scoring of the 2 independent coders. AHI was calculated 
as the number of obstructive apneas and hypopneas per hour of 
sleep. Obstructive apnea was defined as a thermal signal ampli-
tude reduction of at least 90%, and hypopnea as a respiratory 
event lasting 10 s or more and presenting a nasal pressure signal 
drop of 50% or more from baseline with over 3% desaturation or 
an arousal  [24] . Microarousals were scored according to the cri-
teria of the American Sleep Disorders Association  [25] .
 Neuropsychological Assessment 
 General cognitive performance was assessed using a short 
form  [26] of the Wechsler Adult Intelligence Scale-Revised  [27] , 
which included the following subtests: Information, Digit Span, 
Arithmetics, Similarities, Picture Completion, Block Design and 
Digit Symbol. Among the executive domains, short-term memory 
span was assessed with the Digit Span forwards and the Spatial 
Span (SSP, span length) of the Cambridge Neuropsychological 
Test Automated Battery (CANTAB). Working memory was as-
sessed with the Digit Span backwards and the Spatial Working 
Memory (strategy) of CANTAB. Verbal fluency assessment com-
prised both semantic (animals) and phonological fluency (letters: 
PAS, a Finnish version of FAS)  [4] . Visuospatial organizational 
skills were assessed with the Rey-Osterrieth Complex Figure Test 
(ROCFT)  [28] and the Block Design. Visuomotor tracking evalu-
ation was based on Trails A of the Trail Making Test  [29] and the 
Digit Symbol. Mental set-shifting was assessed with Trails B of 
the Trail Making Test and the Intra-Extra Dimensional Set-Shift-
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ing (IED, stages completed and errors) of CANTAB. Planning and 
problem solving was assessed with Stockings of Cambridge (SOC, 
problems solved) of CANTAB.
 Statistical Analyses 
 Mean values, standard deviations (SD) and ranges were used 
as descriptive values. Since some of the parameters were not nor-
mally distributed and the sample sizes were small, the decision 
was made to use nonparametric tests. The patient and control 
groups were compared using the Mann-Whitney U test. Com-
parisons within these two study groups from baseline to follow-
up assessment were performed using the Wilcoxon test. The sig-
nificance level was set at 0.05 for all analyses, values from 0.05 to 
0.1 were considered to show a tendency towards a significant re-
sult. All reported p values are based on two-tailed tests. 
 Results 
 Pre-CPAP 
 The mean age for the 20 OSAS patients was 50 years 
(range 37–65) and for the 17 controls 44 years (range 30–
63). The patient group was slightly older than the control 
group (p = 0.049). The mean length of education for pa-
tients was 13 years (range 5–17) and for controls 14 years 
(range 8–17); this difference was not significant. The val-
ues for subjective sleepiness, body mass index (BMI) and 
polysomnographic data are presented in  table 1 . Patients 
were sleepier than controls as assessed with the Epworth 
Sleepiness Scale, and more obese than controls. Patients 
had mild to severe OSAS with fragmented sleep and hy-
poxemic events. Nine patients did not have any medica-
tion, 6 patients had medication for hypertension, 4 pa-
tients had medication for high cholesterol, and 1 patient 
had antiaggregation medication. None of the controls 
had medication.
 Mean IQ was 115 (range 99–125) for patients and 118 
(range 104–137) for controls; this difference was nonsig-
nificant. The results of the executive tests ( table 2 ) showed 
that newly diagnosed OSAS patients performed more 
poorly in the ROCFT, Block Design, Trails B and IED 
(stages completed). All controls performed at optimal lev-
el in the IED, reaching 9 stages, while 6 patients reached 
only 7 or 8 levels. Patients also performed more poorly in 
the Digit Symbol, and the difference between the groups 
in the SSP showed a tendency towards statistical signifi-
cance. 
 Post-CPAP 
 Mean CPAP adherence was 6.2 h per night (range 4.3–
8.6), and the mean duration of CPAP treatment was 7.4 
months (range 6–12). Neuropsychological follow-up as-
sessment of the controls was conducted on average 7.2 
months (range 6–12) after the baseline assessment. The 
interval between the baseline and follow-up assessments 
did not differ between the two groups. Patients’ post-
CPAP values for subjective sleepiness, BMI and polysom-
nographic data are presented in  table 1 . Subjective sleepi-
Table 1.  Mean 8 SD and range of subjective sleepiness, obesity and polysomnographic variables in controls and patients before (pre-
CPAP) and after (post-CPAP) CPAP treatment and comparisons
Controls: baseline (A) Patients: pre-CPAP (B) Patients: post-CPAP (C) A vs. B1 B vs. C2
ESS 3.882.3 (0–9) 12.483.8 (5–18) 7.583.9 (1–17) <0.001 0.002
BMI 24.482.5 (20–28) 31.084.6 (25–41) 31.085.1 (21–41) <0.001 NS
TST 428.2854.1 (328–527) 434.8851.8 (375–532) 400.3855.7 (264–503) NS 0.009
SEI, % 89.786.9 (74–98) 90.186.4 (80–98) 87.989.7 (58–97) NS NS
AHI, n/h 2.982.0 (0–5) 47.9824.3 (14–103) 2.183.6 (0–14) <0.001 <0.001
ARI, n/h 13.184.7 (4–23) 38.1821.9 (8–100) 15.486.0 (5–27) <0.001 <0.001
ODI4%, n/h 0.981.5 (0–6) 33.0824.2 (0–88) 0.880.8 (0–3) <0.001 <0.001
S1% 6.683.8 (2–16) 5.182.5 (1–11) 6.183.6 (2–16) NS NS
S2% 59.887.2 (45–72) 73.186.9 (60–85) 67.088.3 (47–79) <0.001 0.005
SWS% 14.285.9 (5–25) 4.484.6 (0–14) 9.287.9 (1–29) <0.001 0.002
REM% 19.585.0 (13–28) 17.584.9 (9–27) 17.784.6 (11–26) NS NS
ESS = Epworth Sleepiness Scale; TST = total sleep time in minutes; SEI = sleep efficiency index of TST; ARI = arousal index;
ODI4% = oxygen desaturation index; S1% = sleep stage 1 percentage of TST; S2% = sleep stage 2 percentage of TST; SWS% = slow wave 
sleep percentage of TST; REM% = rapid eye movement sleep percentage of TST.
1 Mann-Whitney U test. 2 Wilcoxon test; p values. 
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ness decreased. BMI did not change significantly. Slow 
wave sleep as a proportion of total sleep time increased, 
while the proportion of sleep stage 2 decreased. Total 
sleep time (in minutes) also decreased. Respiratory defi-
cits, arousals and hypoxemic events normalized. 
 Comparing patients’ post-CPAP results with the fol-
low-up results for controls, patients continued to show 
poorer performance than controls in the ROCFT, Block 
Design, Digit Symbol and Trails B. The difference be-
tween the two groups in the IED showed a tendency to-
wards statistically significant poorer performance for pa-
tients. Again, all controls performed in the IED at opti-
mal level, reaching 9 stages, while 1 of the patients now 
reached only 3 stages, and 3 patients reached 7 stages. In 
addition, patients now performed more poorly than con-
trols in the Trails A, SSP and SOC. These differences were 
not statistically significant at the baseline assessment. No 
significant changes were seen in the patients’ executive 
test performance from pre-CPAP assessment to post-
CPAP assessment in any test. The controls’ performance, 
on the other hand, improved statistically significantly 
from baseline to follow-up assessment in the Block De-
sign and Trails A. Controls also showed a tendency to-
wards statistically significant improvement from base-
line to follow-up assessment in the Digit Symbol and 
SOC. 
 Discussion 
 In this study, we set out to investigate the impact of 
CPAP treatment on executive dysfunction in OSAS pa-
tients. Before CPAP treatment, OSAS patients showed 
mildly impaired mental set shifting performance and vi-
suospatial organizational skills compared to healthy con-
trols, which is in line with our earlier results with a larg-
er patient sample  [8] . After at least 6 months of CPAP 
treatment, OSAS patients’ executive performance showed 
no improvement and they continued to perform more 
poorly than healthy controls. In addition, OSAS patients 
showed no learning effect in executive tests, while healthy 
controls did.
 Our findings confirm the results of earlier studies ac-
cording to which executive functions are not totally re-
versible even with long-term CPAP treatment  [5–7, 9] . 
Our result which showed persisting decline in mental set-
shifting is in line with the finding of Bédard et al.  [5] , who 
reported that impaired performance in the Trails B re-
mained after 6 months of CPAP treatment. Feuerstein et 
al.  [6] and Naegelé et al.  [7] , by contrast, reported that 
OSAS patients’ mental set-shifting performance normal-
ized after CPAP treatment lasting 4–6 months. In their 
studies, mental set-shifting was assessed with the Wis-
consin Card Sorting Test  [30] , which is used to measure 
Table 2. M ean 8 SD and range of executive tests in controls at baseline and at follow-up and in patients before (pre-CPAP) and after 

















Digit span (f) 7.082.0 (4–11) 6.782.5 (4–10) 7.081.7 (4–10) 7.081.7 (3–10) NS NS NS NS
Digit span (b) 6.881.6 (4–10) 7.581.8 (5–12) 6.881.3 (4–9) 6.781.8 (3–10) NS NS NS NS
SSP 7.381.4 (5–9) 7.781.3 (5–9) 6.681.2 (5–8) 6.681.3 (5–9) (0.070) 0.011 NS NS
SWM 28.786.9 (19–39) 28.086.0 (19–37) 30.187.5 (19–43) 30.787.4 (19–42) NS NS NS NS
Fluency (s) 25.784.7 (16–31) 24.184.1 (18–31) 24.484.7 (16–34) 24.285.2 (15–34) NS NS NS NS
Fluency (p) 42.1811.9 (27–59) 46.2813.7 (20–79) 42.9813.1 (29–74) 42.6812.2 (23–66) NS NS NS NS
ROCFT 35.280.9 (34–36) 35.381.0 (33–36) 33.582.4 (29–36) 34.182.2 (28–36) 0.018 0.047 NS NS
Block design 40.588.3 (23–51) 43.489.3 (22–51) 34.589.3 (14–49) 34.489.7 (15–49) 0.039 0.002 0.014 NS
Digit symbol 57.0814.9 (35–88) 59.7812.5 (39–78) 45.2810.8 (28–66) 45.9811.8 (23–67) 0.011 0.003 (0.093) NS
Trails A 31.9811.5 (14–61) 25.886.7 (16–39) 36.6813.0 (19–66) 35.6815.4 (16–76) NS 0.025 0.024 NS
Trails B 65.4830.7 (31–128) 61.1830.9 (35–153) 89.4847.4 (42–230) 78.6830.9 (38–161) 0.034 0.022 NS NS
IED stages 9.080.0 (9–9) 9.080.0 (9–9) 8.680.7 (7–9) 8.481.5 (3–9) 0.013 (0.062) NS NS
IED errors 13.186.8 (7–28) 9.482.6 (7–18) 20.0814.2 (7–45) 17.1810.9 (6–39) NS (0.054) NS NS
SOC 10.181.9 (6–12) 10.682.2 (5–12) 9.682.2 (3–12) 9.481.9 (5–12) NS 0.021 (0.051) NS
p values in parentheses refer to values showing a tendency towards statistically significant difference. f = Forwards; b = backwards;
SWM = spatial working memory; s = semantic; p = phonological. 
1 Mann-Whitney U test. 2 Wilcoxon test; p values.
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similar executive functions as are assessed with the IED 
used in our study. Our findings of persisting decline in 
visuospatial organizational skills are supported by the re-
sults of Ferini-Strambi et al.  [9] , who reported that among 
other executive domains, performance in the ROCFT 
and Block Design remained impaired both after short-
term (15 days) and long-term (4 months) CPAP treat-
ment. However, in contrast to our findings, Bédard et al. 
 [5] reported a normalization of both visuospatial organi-
zational skills and visuomotor tracking after 6 months of 
CPAP. In placebo-controlled studies, Engleman et al.  [17, 
18] reported that CPAP produced a greater improvement 
in mental set-shifting as assessed with the Trails B than 
did placebo treatment. However, most placebo-controlled 
studies have found no improvement in either mental set-
shifting performance or in visuospatial organizational 
skills over placebo  [13, 14, 16, 19] . 
 There are several possible explanations for the incon-
sistent evidence regarding the impact of CPAP on execu-
tive dysfunction. Firstly, executive functions are mea-
sured using different tests and therefore the results are 
not directly comparable. Secondly, the neuropsychologi-
cal tests used in clinical practice are not necessarily sensi-
tive enough to detect positive treatment effects, especial-
ly in patients with high mental functioning  [31] . Recent 
studies  [10, 16] have shown that more complex neuropsy-
chological tasks (e.g. PASAT, n-back working memory 
tasks and Digit Vigilance)  [4] that require cognitive pro-
cessing speed, vigilance and working memory seem to be 
more sensitive to the effects of CPAP. Thirdly, the com-
parability of results is affected by the heterogeneity of pa-
tient samples and by the differences in CPAP treatment 
adherence and duration. 
 A noteworthy finding in our results is that OSAS pa-
tients showed no learning effect in executive tests, while 
healthy controls did. Executive tests are ‘one-shot’ tests 
based on novelty and strategy formation  [32] , and the 
learning effect may be significant when retesting OSAS 
patients after CPAP treatment. Especially in measure-
ments of the short-term effects of CPAP, OSAS patients 
seem to improve their performance over time, and with-
out placebo control this improvement may be misattrib-
uted to CPAP  [16] . Earlier studies focusing on the long-
term effects of CPAP on cognitive and executive func-
tions  [5–7, 9] have not used comparison groups after 
CPAP, but parallel or alternative test versions to decrease 
the learning effect. However, this is not necessarily 
enough; when a patient figures out the basic idea of the 
test, that may be much easier to do the second time round, 
even if the material is different from the original test. Our 
finding that healthy controls could improve their perfor-
mance while OSAS patients could not, raises the possibil-
ity that OSAS patients are less well equipped to learn from 
experience. This may have to do with the fact that execu-
tive dysfunction and long-term memory deficits often 
overlap: OSAS patients may have poorer learning and 
memory skills because due to frontal dysfunction, they 
have deficits in memory organization  [33] . The recording 
of new experiences and consolidation of declarative 
memories are dependent on the cooperation of prefrontal 
and hippocampal functions, and this process can easily 
be disrupted by inadequate sleep, especially the lack of 
slow wave sleep  [34] that is seen in OSAS patients.
 Cognitive dysfunction in OSAS seems to be a multi-
factorial phenomenon. Sleepiness, sleep fragmentation, 
hypoxemia and hypercarbia may all have an impact on 
cognitive function  [3, 35] . In our study group, OSAS pa-
tients’ disease severity based on AHI was mainly moder-
ate to severe, and it is possible that this made our patients 
more vulnerable to cognitive changes. Cognitive prob-
lems may also be increased by OSAS-related health prob-
lems like obesity, hypertension, metabolic syndrome, di-
abetes and increased risk for cerebrocardiac vascular 
problems  [36] . Comorbidity was seen also in our patient 
group; half of the OSAS patients had medication for hy-
pertension, high cholesterol or antiaggregation medica-
tion.
 In this study we took the decision to use a healthy con-
trol group not only at baseline, but at the follow-up assess-
ment as well. This allowed us to control the impact of any 
learning effect on executive test performance. One limi-
tation of our study is that patients who used CPAP ade-
quately tended to be older than those who did not. How-
ever, the two groups did not differ in terms of their edu-
cation or IQ. In addition, the pretreatment findings 
regarding OSAS patients’ poorer performance in mental 
set-shifting and visuospatial organizational skills were 
mostly the same as in our previous studies with age-
matched study groups  [8] . Another limitation is that the 
study groups had differences in their sleep condition pri-
or to the neuropsychological control assessment. This 
may have some effect on patients’ cognitive performance 
on the next morning because of generally poorer sleep 
quality under laboratory conditions. This may be par-
ticularly true in tasks that require cognitive processing 
speed (e.g. Trails A). However, we believe that an im-
paired learning effect in executive tests is affected main-
ly by long-term effects of OSAS. Based on our relatively 
small sample size, we assume that although CPAP may 
generally have a positive influence on OSAS patients’ ex-
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ecutive dysfunction, it seems to have only a minor effect 
on the mild decline seen in their mental set-shifting and 
visuospatial organizational skills. Our finding of OSAS 
patients’ impaired learning in executive tests should be 
investigated more thoroughly. 
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ABSTRACT
The aims of this study are to clarify whether patients with obstructive
sleep apnea syndrome (OSAS) have a decline in verbally or visually-
based cognitive abilities and whether the possible decline is related to
particular sleep depth changes. In addition, the effect of continuous
positive airway pressure (CPAP) on the possible changes is investi -
gated. Fifteen OSAS patients and 15 healthy controls joined two full-
night polysomnographies, including a computational measure of deep
sleep percentage (DS%) bilaterally from the frontal, central and occipital
channels, and a neuropsychological assessment. After a 6-month CPAP
the patients underwent one more full-night polysom nography with com -
putational DS% analysis and a neuropsychological assessment. 
At the baseline, the OSAS patients had poorer performance in the
Picture Completion, in the Digit Symbol and in copying the Rey-
Osterrieth Complex Figure Test (ROCFT) compared to the controls.
The patients also showed reduced DS% in all 6 electrographic (EEG)
channels compared to controls. The patients had an inter-hemispheric
difference showing less deep sleep in the right hemisphere than in the
left hemisphere both frontopolarly and centrally, while the controls
showed this inter-hemispheric difference only frontopolarly. After CPAP
the patients still had poorer performance in the Picture Completion and
in the ROCFT. The patients continued to show reduced DS% in all 3
channels of the right hemisphere and occipitally in the left hemisphere,
also the inter-hemispheric difference frontopolarly and centrally
remained. OSAS patients have mild visually based cognitive
dysfunction and reduced amount of deep sleep in the right hemisphere
even after CPAP.
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is characterized by
repetitive episodes of complete (apnea) and partial (hypopnea)
obstructions of the upper airway during sleep and results in oxygen
desaturation and fragmented sleep.1 OSAS is associated with
cognitive decline. Deficits in executive functions, information proces -
sing speed, vigilance and long-term memory are the most obvious.2-4 In
contrast, the findings of changes in verbal and visual abilities are
inconsistent. Verbal abilities like naming and conceptual formatting are
usually intact,3,4 but verbal fluency is adversely affected more often.5-10
However, verbal fluency is also reported to be preserved in some
studies.11,12 Changes in visuoconstructive and visuomotor performance
are quite common,3,6,9,10,13 but not all studies have confirmed the
visuomotor deficits.14 Continuous positive airway pressure (CPAP)
treatment improves visual skills,9 but visuoconstructive and visuomotor
problems may persist.3,6 Also reduced verbal fluency may remain.6,9,15
The left hemisphere of the brain is dominant in verbal cognitive
function and the right hemisphere in visual cognitive function. While the
left hemisphere is found to be superior during wakefulness, the right
hemisphere seems to be capable of operating at reduced arousals
levels.16,17 EEG changes induced by sleep deprivation suggest that the
left hemisphere needs more sleep than the right hemisphere, maybe
because it is more active during wakefulness.18 Also, the prefrontal
cortex seems to need more slow wave sleep (SWS) than the central
cortex.19 The amount of SWS seems to be especially important to good
sleep quality and refreshing sleep.20,21 The fragmented sleep in OSAS
patients has been reported to cause anterior located unihemispheric
sleep EEG differences; in untreated OSAS patients, the amount of slow
delta wave sequences in the left prefrontal EEG-derivation was reduced
when compared to healthy controls,22 and CPAP treatment increased
SWS more on the left prefrontal than on the left central area.23
It is possible that sleep depth changes might be related to daytime
cognitive functioning. In the present study, we were interested in
investigating if the possible verbal and visual cognitive dysfunction in
OSAS is related to sleep EEG changes. We used the previously
described computational method in quantifying the amount of deep
sleep.24-26 We set out to examine: 1) whether OSAS patients have a
decline in verbally or visually-based cognitive skills; 2) whether OSAS
patients show deep sleep changes; and 3) whether CPAP treatment
has an effect on the possible changes. 
SUBJECTS AND METHODS
Subjects
All the subjects, 15 OSAS patients and 15 healthy volunteer control
subjects, were male. The mean age for the patients was 50 years
(range: 37-59) and for the controls 44 years (range: 30-63). The mean
length of education for the patients was 12 years (range: 5-17) and for
the controls 13 years (range: 8-17). The groups did not differ
significantly in terms of age (p = 0.085) or education (p = 0.356). The
study was conducted in a sleep unit of a university hospital. Patients
were referred to the unit because of possible OSAS. The sample
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included 30 OSAS patients who met the diagnostic criteria and whose
first treatment choice was CPAP. Fifteen of them used CPAP treatment
regularly for 6 months and were included into this study. 
Both the patients and the controls were first interviewed by
telephone to make sure they met the initial eligibility criteria: a) age
between 20 and 65 years, b) right-handedness, c) no (other) sleep
disorders, d) no clinically significant medical disorder (e.g.,
neurological illness, psychiatric disorder, hypo-/hyperthyroidism or
other lung diseases than currently asymptomatic asthma), f) no
medication affecting central nervous system, g) no substance or
alcohol abuse, and h) no self-reported primary perception disorder.
The patients’ OSAS diagnosis and the controls’ healthiness were then
confirmed with a clinical interview and a diagnostic full-night
polysomnography in a sleep laboratory. The diagnosis of OSAS was
based on a clinical picture and subjective complaints of OSAS1 and on
an apnea/hypopnea index (AHI) > 10 per hour of sleep. The controls
had to be asymptomatic and had an AHI of ≤ 5 per hour of sleep. The
study was approved by the Ethical Committee of the Hospital District.
The subjects gave their written informed consent.
Procedure and measures
The patients and controls who according to the first night
polysomnography met the eligibility criteria underwent a second full-
night polysomnography and a neuropsychological assessment on the
following morning. Subjective sleepiness was evaluated with the
Epworth Sleepiness Scale (ESS).27 Of the 2 diagnostic nights, the
recordings for the latter night were used in the analyses. After 6
months of CPAP treatment the patients underwent one full-night
polysomnography (the treatment night) and a neuropsychological
control assessment on the following morning. The minimum required
CPAP treatment time was 6 months and minimum adherence at least
4 hours per night and at least 5 nights per week. Objective
compliance measures were downloaded from CPAP units prior to the
treatment night.
Polysomnography 
Subjects retired to bed between 10pm and 12pm according to their
own habitual bed times. Six EEG derivations (Fp1-A2, Fp2-A1, C3-A2,
C4-A1, O1-A2 and O2-A1), 2 electro-oculography channels,
submental muscle tonus, electrocardiogram, airflow pressure by nasal
transducer, thermistor, thoracoabdominal respiratory movements and
blood oxygen saturation were recorded. In addition, transcutaneous
carbon dioxide tension, leg movements, body position and body
movements were recorded. The second diagnostic night and the
treatment night were classified by 2 independent scorers into the old
sleep stages from C3-A2 channels.28 The Somnologica‚ software
(Medcare/Flaga, Iceland) was used for visual analyses. The level of
agreement between the 2 scorers was 86.0% (p = 0.76). Based on
their independent scorings, the 2 scorers formed a consensus sleep
staging, which was used in the statistical analyses. The AHI was
calculated as the number of obstructive apneas and hypopneas per
hour of sleep. Obstructive apneas were defined as at least 90%
reduction in the thermal signal amplitude, whereas hypopneas were
defined as diminution of at least 50% of the nasal pressure signal. For
hypopneas a concomitant desaturation of 4% was used as an
additional criterion. Microarousals were scored according to the
criteria of the American Sleep Disorders Association.29
Computational deep sleep percentage (DS%)
A computational EEG mean frequency measure can be used to
quantify sleep depth.24-26,30 In the present work, EEG signal
segmentation of 2-s duration was used, selection based on the work by
Saastamoinen and coworkers.24 The 2-s long signal segment was
centered at the kth second in the recording. After the mean removal,
each 2-s long EEG signal segment was windowed with a Hanning
window function, denoted as wn, where n = 1,…, L, and L= 400. This
sequence was then zero-padded to a length of 1024 and the fast
Fourier Transform (FFT) was taken of the entire sequence providing
the complex-valued spectrum, denoted as R(f) = X(f) + jY(f), where f
denotes the frequency and j denotes the imaginary unit. The spectrum
was then scaled to the amplitude spectrum, denoted as A(f), as follows: 





A frequency band of 0.58-30.1 Hz was utilized in the present mean
frequency computation, selected based on the work by Saastamoinen
and coworkers.24 A cumulative distribution function, denoted as c(f),
ranging from 0 to 1, was first formed as follows:
f 30.1Hz
C(f) = ∑ A(fi) / ∑ A(fi)
fi=0.58Hz fi=0.58Hz
The mean frequency was then obtained as the frequency f where
c(f)= 0.5. Six EEG channels were examined in the present work. A
mean frequency value at each second k was first computed from each
EEG channel separately. This provided six sleep depth curves during
the night. A 201-s long median filtering was then applied to smooth the
sleep depth curves, as in the studies by Huupponen and coworkers.25,26
In the present study, the visual sleep staging was utilized and the
deep sleep percentage (DS%) was extracted during the NREM sleep
time from each of the six smoothed sleep depth curves. The value of
DS% therefore is, in percentage, the proportion of NREM sleep time
containing deeper sleep than the threshold of 4.0 Hz. The resulting DS%
value computed from the EEG channel Fp1-A2 was denoted as
DS(Fp1)%, and the others values, respectively as DS(Fp2)%, DS(C3)%,
DS(C4)%, DS(O1)%, and DS(O2)%.
Neuropsychological assessment
General cognitive performance was assessed with a short form31 of
the Wechsler Adult Intelligence Scale -Revised (WAIS-R32), as Décary
and coworkers33 have recommended. The verbally-based cognitive
abilities were assessed with the WAIS-R verbal subtests: Information,
Digit Span, Arithmetics and Similarities, and visually-based cognitive
abilities with visual subtests: Picture Completion, Block Design and
Digit Symbol. In addition, the Controlled Word Association Test
(COWAT34) including semantic (animals) and phonemic (letters P-A-S;
a Finnish version of F-A-S) fluency was used to assess verbal abilities,
and the copy of Rey-Osterrieth Complex Figure Test (ROCFT35) to
assess visual abilities. 
Statistical analyses 
Mean values, standard deviations (SD) and ranges were used as
descriptive values. Since some of the parameters were not normally
distributed and the sample sizes were small, nonparametric tests were
chosen. The 2 subject groups were compared using the Mann-Whitney
U test. The patient group at baseline and at follow-up was compared
using the Wilcoxon test. The Wilcoxon test was also used to compare
inter-hemispheric DS% differences within the groups. A significance
level was set at 0.05 for all analyses. All reported p-values are based
on two-tailed tests. 




Descriptive values of subjective sleepiness, body mass index
(BMI), polysomnographic data and DS% are presented in Table 1. At
baseline the patients were sleepier as assessed with the ESS and had
a higher BMI than the controls. The patients had moderate to severe
OSAS with sleep fragmentation, hypoxemic episodes, and reduced
SWS% of the total sleep time. 
The mean estimated intelligence quotient (IQ) for the patients was
113.4 (SD: 7.6; range: 99-125) and for the controls 118.2 (SD: 11.2;
range: 104-137). The groups did not differ significantly in terms of IQ (p
= 0.430). The other results of the neuropsychological assessment are
presented in Table 2. The patients performed more poorly compared to
the healthy controls in the Picture Completion and the Digit Symbol
subtests of the WAIS-R, and in the copy of ROCFT. 
The patient group had reduced DS% values in all 6 EEG channels
compared to the control group. The patients showed a lower DS% in
the right hemisphere than in the left hemisphere both frontopolarly and
centrally (p-values 0.001 and 0.009, respectively), but occipital
recordings showed no significant inter-hemispheric difference. The
controls presented a lower DS% in the right prefrontal derivation (p =
0.011) compared to the left side but had no other significant inter-
hemispheric differences. 
Post-CPAP
The mean CPAP treatment time was 7.2 months (range: 6-12) and
the mean adherence 6.1 hours per night (range: 4.3-8.6). The descriptive
values of subjective sleepiness, BMI, polysomnographic data and DS%
are presented in Table 1. After CPAP treatment the patients’ subjective
sleepiness reduced but was still higher than controls’. BMI did not
change significantly. Respiratory deficits, arousals and hypoxemic
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Table 1
Mean (SD) and range of subjective sleepiness, body mass index, polysomnographic data and deep sleep percentage 
in the control group and in the patient group before (pre-CPAP) and after (post-CPAP) CPAP treatment and the comparisons
- A - - B - - C - A vs B1 A vs C1 B vs C2
Controls Patients pre-CPAP Patients post-CPAP
ESS 4.1 (3.1) 12.0 (4.0) 7.9 (4.2) p < 0.001 p = 0.012 p = 0.014
0 – 11 5 – 17 1 - 17
BMI 24.1 (2.5) 31.8 (4.6) 32.3 (4.7) p < 0.001 p < 0.001 ns
20.1 – 28.1 25.4 - 41.4 26.0 - 41.0
AHI 2.9 (2.0) 49.5 (24.0) 2.6 (4.0) p < 0.001 ns p = 0.001
0 – 5 16 – 103 0 - 14
ARI 13.1 (5.0) 38.2 (22.6) 14.5 (13.7) p < 0.001 ns p = 0.001
4.3 - 22.8 8.0 - 99.6 4.6 - 27.0
ODI4 1.0 (1.6) 33.6 (25.1) 0.8 (0.9) p < 0.001 ns p = 0.001
0.0 - 6.0 2.0 - 88.0 0.0 - 3.0
S1% 5.7 (3.0) 4.7 (2.4) 5.8 (4.0) ns ns ns
2.2 - 15.0 1.2 - 11.2 1.5 - 16.1
S2% 62.6 (6.2) 74.4 (6.0) 68.8 (7.7) p < 0.001 p = 0.038 p = 0.006
52.0 – 71.7 65.8 - 85.3 56.2 - 79.0
SWS% 11.5 (11.9) 3.5 (3.3) 6.4 (6.1) p < 0.001 p = 0.007 p = 0.011
2.1 - 20.6 0.0 - 11.7 0.6 - 24.2
REM% 20.2 (4.9) 17.4 (4.7) 19.0 (4.4) ns ns p = 0.001
13.6 – 27.8 8.6 - 27.3 12.4 - 26.4
DS(Fp1)% 24.8 (12.7) 13.1 (10.6) 18.3 (11.6) p = 0.017 ns p = 0.036
6.2 - 48.8 0.0 - 30.2 0.0 - 33.3
DS(Fp2)% 21.1 (12.3) 6.5 (7.7) 10.3 (9.3) p = 0.002 p = 0.018 ns
0.0 - 39.3 0.0 - 21.5 0.0 - 24.7
DS(C3)% 13.2 (11.0) 4.8 (4.6) 9.2 (8.3) p = 0.024 ns p = 0.019
0.0 - 29.6 0.0 - 11.8 0.0 - 24.4
DS(C4)% 12.8 (10.2) 2.8 (3.3) 5.1 (5.4) p = 0.016 p = 0.013 p = 0.022
0.0 - 29.7 0.0 - 11.9 0.0 - 15.4
DS(O1)% 10.0 (11.8) 1.1 (2.6) 2.2 (3.5) p = 0.004 p = 0.027 ns
0.0 - 37.4 0.0 - 8.3 0.0 - 9.8
DS(O2)% 11.8 (12.6) 1.5 (2.6) 1.9 (3.1) p = 0.016 p = 0.022 ns
0.0 - 42.9 0.0 - 9.1 0.0 - 11.0
1Mann-Whitney U test; 2Wilcoxon test
ESS = Epworth Sleepiness Scale; BMI = body mass index; AHI = apnea/hypopnea index; ARI = arousal index; ODI4 = oxygen desaturation index;
S1% = sleep stage 1 percentage of total sleep time; S2% = sleep stage 2 percentage of total sleep time; SWS% = slow wave sleep percentage of
total sleep time; REM% = rapid eye movement sleep percentage of total sleep time; DS(Fp1)%, DS(Fp2)%, DS(C3)%, DS(C4)%, DS(O1)%, DS(O2)%
= computational deep sleep percentages extracted from EEG channels Fp1-A2, Fp2-A1, C3-A2, C4-A1, O1-A2, O2-A1
events normalized. The percentage of sleep stage 2 of the total sleep
time (S2%) decreased, SWS% and the percentage of rapid eye
movement sleep of the total sleep time (REM%) increased, but the
patients still showed higher S2% and lower SWS% than the controls. 
In the neuropsychological tests the patients’ results did not change
statistically significantly in the Digit Symbol based on the Wilcoxon test,
but the patients did not differ statistically significantly from the controls
any more. The patients still showed lower performance in the Picture
Completion and in the copy of ROCFT (Table 2). 
The DS% increased frontopolarly in the left hemisphere and
centrally on both hemispheres but not occipitally. CPAP treatment
normalized the DS% to the same level as the controls’ frontopolarly and
centrally in the left hemisphere whereas the patients continued to show
reduced DS% in other derivates. During CPAP treatment the inter-
hemispheric differences within the patient group remained. The DS%
persisted lower both frontopolarly and centrally in the right hemisphere
than in the left hemisphere (p-values 0.001 and 0.008, respectively).
DISCUSSION
In this study, OSAS patients showed slightly lower performance in
tests of visually-based cognitive skills. Differences compared to
healthy controls were observed in visual perception, visuospatial or
visuoconstructive organizational skills, and visuomotor performance.
Before CPAP treatment, OSAS patients showed a reduced deep sleep
percentage (DS%) compared to controls in both hemispheres frontally,
centrally and occipitally. After 6 months of CPAP treatment, patients
continued to show mild visual dysfunction and a reduced DS%
compared to controls in all 3 derivations of the right hemisphere and
occipitally in the left hemisphere. In the examination of inter-
hemispheric differences within the study groups, OSAS patients
showed a lower DS% in the right hemisphere than in the left
hemisphere both frontopolarly and centrally, while controls showed this
inter-hemispheric difference only frontopolarly.
Most of our findings on visual dysfunction are in line with earlier
results.3,6,9,10,13 In keeping with the findings here, earlier studies have
reported only minor differences between OSAS patients and controls,6,13
especially when OSAS is moderate.10 However, our finding concerning
the mild decline in visual perception in OSAS patients is less common.
According to the meta-analysis by Beebe and coworkers,4 OSAS
markedly affects drawing and fine-motor coordination, but has less
effect on visual perception and motor speed. As in previous reports, we
found that verbal cognitive skills remained intact in OSAS.3,4,11,12 On the
other hand, we found no change in verbal fluency tasks.5-10
At baseline, OSAS patients showed a reduced DS% compared to
controls in all selected EEG locations. This is possibly explained by the
effect of apneas, hypopneas and desaturations which disturb the sleep
process in OSAS and make it difficult to reach enough deep sleep. The
reduced amount of deep sleep might be connected with the cognitive
changes because it is thought that the amount of deep sleep expresses
the goodness and refreshing effect of sleep.20,21 However, even though
the amount of DS% was reduced bilaterally, only visual-based cognitive
and not verbal dysfunction was detected. This raises the question as to
whether the left hemisphere is more capable of maintaining cognitive
functions even in the event of sleep quality changes.
The finding that healthy controls present an inter-hemispheric
difference in the amount of DS% is noteworthy. According to
Casagrande and Bertini,16 the left hemisphere seems to fall into sleep
earlier than the right hemisphere as judged by both behavioral and EEG
criteria. This might be indicative of a high need for restorative sleep in
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Table 2
Mean (SD) and range of cognitive performance in the control group and in the 
patient group before (pre-CPAP) and after (post-CPAP) CPAP treatment and the comparisons
- A - - B - - C - A vs B1 A vs C1 B vs C2
Controls Patients pre-CPAP Patients post-CPAP
Information 25.9 (4.2) 24.1 (5.0) 24.1 (4.5) ns ns ns
7 – 31 11 – 30 13 - 30
Digit Span 13.4 (2.7) 13.5 (3.0) 13.9 (2.6) ns ns ns
10 – 20 8 – 18 9 - 18
Arithmetics 19.3 (3.2) 19.1 (2.4) 18.9 (2.4) ns ns ns
14 – 24 13 – 24 14 - 22
Similarities 27.2 (2.8) 27.7 (2.8) 28.5 (2.7) ns ns ns
21 – 32 23 – 32 23 - 33
Phonemic Fluency 42.5 (11.9) 41.7 (12.1) 41.6 (10.9) ns ns ns
28 – 59 29 – 74 23 - 56
Semantic Fluency 25.3 (5.0) 23.7 (4.1) 24.3 (4.4) ns ns ns
16 – 31 16 – 32 16 - 31
Picture Completion 19.1 (1.3) 17.4 (2.1) 18.1 (1.6) p = 0.010 p = 0.048 ns
16 – 21 13 – 20 16 - 22
Block Design 40.2 (9.1) 34.3 (10.0) 34.3 (10.5) ns ns ns
23 – 51 14 – 49 15 - 49
Digit Symbol 56.0 (15.4) 43.7 (10.4) 45.2 (11.4) p = 0.038 ns ns
35 – 88 28 – 66 23 - 65
ROCFT 35.1 (1.0) 32.5 (2.4) 33.5 (2.2) p = 0.002 p = 0.023 ns
33 – 36 29 – 36 28 - 36
1Mann-Whitney U test; 2Wilcoxon test
ROCFT = Copy of Rey-Osterrieth Complex Figure Test
the left hemisphere, which is known to be very active during the
daytime. Indeed, Casagrande and Bertini17 and Achermann and
coworkers18 have suggested that the right hemisphere might not need
as much deep sleep as the left one. Casagrande and Bertini17 have
proposed that the right hemisphere could maintain waking ability when
the brain is going to sleep or is in sleep and to tolerate sleep loss better
than the left hemisphere. This dominance of the right hemisphere in the
vigilance system, Casagrande and Bertini17 hypothesize, would enable
it to watch out for potential warning stimuli even in sleep. If this theory
is correct, it might be a natural rather than an abnormal situation that
healthy controls show less deep sleep in the right frontopolar area than
in the left one during normal sleep. However, in our study OSAS
patients showed a lower DS% both frontopolarly and centrally in the
right hemisphere than in the left hemisphere. This reduced DS% in a
larger area of the right hemisphere might indicate that in OSAS patients
the right hemisphere is on the lookout for possible warning stimuli such
as respiratory deficits and the central cortex is also needed to make this
possible. This fits in the theory of Sturm and co-workers36 according to
which the attention and vigilance system is based on the right fronto-
parietal-thalamic-brainstem network. 
The mild dysfunctions observed in our patients in visual perception
and visuospatial or constructive skills persisted during CPAP. Although
the number of cortical arousals returned to normal, DS% remained low
in the right hemisphere. This might support the view that these
dysfunctions are in fact visually-based cognitive changes, although
other cognitive functions may also have affected the patients’
performance. OSAS patients had reduced DS% bilaterally on the
occipital areas compared to controls before and after CPAP treatment,
and the amount of DS% in occipital tracings did not increase
significantly during treatment. Whether occipital DS% changes are
related to the observed visual dysfunction in OSAS patients lies in the
realm of speculation. 
After CPAP treatment, OSAS patients continued to show inter-
hemispheric difference on both prefrontal and central cortex and to
have a reduced DS% compared to controls in all recordings from the
right hemisphere and occipitally in the left hemisphere. The question
remains as to whether the right hemisphere continues to monitor
respiratory deficits, even though CPAP treatment is expected to
prevent episodes of apnea and hypopnea. Perhaps through this
monitoring process the right hemisphere enables the left hemisphere
to sleep more deeply. 
The strength of our study lies in the inclusion of both computational
EEG analysis and neuropsychological methods to assess OSAS
patients. The smallness of our material, however, necessitates a larger
future study. 
CONCLUSION
OSAS patients have mild visually-based cognitive dysfunctions and
less computational deep sleep in the right hemisphere even during
CPAP treatment. The analysis of local sleep EEG changes may help
explain the cognitive dysfunction in OSAS.
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